Original Article
Prevention of Neural-Tube Defects with Folic Acid in China
N Engl J Med 1999; 341:1485-1490November 11, 1999
- Abstract
Background
Periconceptional use of multivitamins containing folic acid can reduce a woman's risk of having a baby with a neural-tube defect.
Methods
As part of a public health campaign conducted from 1993 to 1995 in an area of China with high rates of neural-tube defects (the northern region) and one with low rates (the southern region), we evaluated the outcomes of pregnancy in women who were asked to take a pill containing 400 μg of folic acid alone daily from the time of their premarital examination until the end of their first trimester of pregnancy.
Results
Among the fetuses or infants of 130,142 women who took folic acid at any time before or during pregnancy and 117,689 women who had not taken folic acid, we identified 102 and 173, respectively, with neural-tube defects. Among the fetuses or infants of women who registered before their last menstrual period and who did not take any folic acid, the rates of neural-tube defects were 4.8 per 1000 pregnancies of at least 20 weeks' gestation in the northern region and 1.0 per 1000 in the southern region. Among the fetuses or infants of the women with periconceptional use of folic acid, the rates were 1.0 per 1000 in the northern region and 0.6 per 1000 in the southern region. The greatest reduction in risk occurred among the fetuses or infants of a subgroup of women in the northern region with periconceptional use who took folic acid pills more than 80 percent of the time. In the southern region the reduction in risk among the fetuses or infants of women with periconceptional use of folic acid was also significant (reduction in risk, 41 percent; 95 percent confidence interval, 3 to 64 percent).
Conclusions
Periconceptional intake of 400 μg of folic acid daily can reduce the risk of neural-tube defects in areas with high rates of these defects and in areas with low rates.
Media in This Article
Table 1
Outcomes among Women Who Registered in the Pregnancy-Monitoring System in One Northern and Two Southern Provinces in China between October 1, 1993, and September 30, 1995.Table 2
Characteristics of the Women for Whom the Status of the Fetus or Infant with Respect to a Neural-Tube Defect Was Known, According to Region and the Use of Folic Acid Pills.Article Activity
- Article
A woman's risk of having a fetus or infant with a neural-tube defect can be reduced by the consumption of a multivitamin containing folic acid during the periconceptional period — before and during the first 28 days after conception. Neural-tube formation is completed during these 28 days, before most women begin taking prenatal vitamins. In 1980, the results of a nonrandomized trial revealed that taking multivitamins during the periconceptional period reduced the risk of having a fetus or infant with a neural-tube defect.1 Since then, observational studies demonstrated a reduced risk among women who took multivitamin supplements containing folic acid2,3 and those who had higher dietary intakes of folate4-6 during early pregnancy.
The efficacy of folic acid in preventing a subsequent occurrence of neural-tube defect among the fetuses or infants of women with a previous affected fetus or infant was first conclusively demonstrated by a Medical Research Council randomized study in the United Kingdom. Women who took 4000 μg of folic acid daily during the periconceptional period in a subsequent pregnancy had a 72 percent reduction in the risk of having an affected fetus or infant.7 Subsequently, Hungarian researchers showed that multivitamin supplements containing 800 μg of folic acid taken periconceptionally reduced the risk of a first occurrence of neural-tube defect.8 The Public Health Service9 has recommended that all women who could become pregnant take 400 μg of folic acid daily, and other countries have also adopted this recommendation.10 We evaluated a public health campaign in China among women preparing for marriage in order to determine the efficacy of a daily dose of 400 μg of folic acid alone in preventing neural-tube defects in two regions of China, one in which the incidence of these defects is high and the other in which it is low.11
Methods
Cohort
The campaign to prevent neural-tube defects was conducted in one northern province of China (Hebei) with relatively high rates of neural-tube defects (5 to 6 per 1000 births) and two southern provinces (Zhejiang and Jiangsu) with lower rates (approximately 1 per 1000 births). All pregnant women and women who were preparing for marriage registered with a pregnancy-monitoring system that serves as the principal record of prenatal care and delivery in all three provinces. We identified women who registered with this monitoring system from October 1993 through September 1995 and who were pregnant at some point between October 1, 1993, and December 31, 1996. The cohort included all women whose fetuses or infants could be confirmed as either having or not having a neural-tube defect. The project was approved by the institutional review boards of the Centers for Disease Control and Prevention and Beijing Medical University, and all women who took pills provided oral informed consent.
Premarital Examination
In China, all couples planning to marry undergo a premarital examination, which includes a physical examination and laboratory tests. Beginning in October 1993, all women who completed this examination were asked to purchase pills containing 400 μg of folic acid and to take one of these pills every day through the end of the first trimester of pregnancy. Each bottle contained 31 pills, and the women were asked to take one bottle of pills each month. Village health workers recorded the dates that the women started and stopped taking folic acid. At the end of each month, the workers recorded how many pills remained in each bottle and the dates of all menstrual periods. For each woman, we computed compliance as the percentage of folic acid pills that were taken as compared with the number that could have been taken.
Use of Folic Acid Pills
We divided the women who took folic acid pills according to the pattern of use on the basis of the dates they started and stopped taking folic acid. We defined women with periconceptional use as those who started taking folic acid pills before their last menstrual period before conception and who stopped at the end of the first trimester. We defined women with late use as those who started taking folic acid pills during the first trimester but sometime after their last menstrual period. We defined women with early discontinuation of folic acid as those who started and stopped taking the pills before their last menstrual period before conception. Women with missing dates were considered unclassifiable and were not assigned to any group. To determine the optimal effect of folic acid supplementation, we identified a subgroup of women who took more than 80 percent of the assigned pills. Women who either did not agree to take the pills at the time of registration or who were already in their second trimester of pregnancy at registration and never had the opportunity to start taking folic acid pills periconceptionally were considered not to have taken folic acid.
Neural-Tube Defects
We identified infants with neural-tube defects through a birth-defects surveillance system. This system, which was established in January 1993, collects detailed data about infants and fetuses with external structural birth defects. Live-born infants with birth defects were included in the surveillance system if they had a gestational age of at least 20 weeks and had a birth defect that was diagnosed by 6 weeks of age.12 We requested photographs of every infant born with a suspected birth defect and of all stillborn infants, whether or not a structural abnormality was recognized. We also collected information on all pregnancies, even those with gestations of less than 20 weeks that were electively terminated after the prenatal diagnosis of any birth defect. Three pediatricians, who were unaware of the women's pill-taking status, independently reviewed the reports and photographs and assigned diagnostic codes, and a clinical geneticist validated the diagnoses. The definition of neural-tube defect included anencephaly, spina bifida, iniencephaly, craniorachischisis, and encephalocele, but not isolated hydrocephalus.
Statistical Analysis
We compared the numbers of women who took folic acid pills and those who did not in each region (northern and southern) according to the time of registration in relation to their last menstrual period, age, level of education, occupation, total number of previous pregnancies, and body-mass index. For each region, we calculated the rate of neural-tube defects (the number of cases per 1000 pregnancies of at least 20 weeks' gestation) according to the use of folic acid. We estimated risk ratios by dividing the risk of neural-tube defects among the fetuses or infants of all women who took folic acid pills by the risk among the fetuses or infants of those who did not take folic acid. We also estimated risk ratios by dividing the risk among the fetuses or infants of women with a periconceptional pattern of use of folic acid by the risk among the fetuses or infants of those with no intake who registered before their last menstrual period. For all risk ratios we used SAS statistical software13 to calculate 95 percent confidence intervals according to the Mantel–Haenszel test.
Results
Characteristics of the Pregnant Women
Among the 285,536 women who registered with health authorities from October 1993 through September 1995, 277,287 (97 percent) were pregnant at some point between October 1, 1993, and December 31, 1996 (Table 1Table 1
Outcomes among Women Who Registered in the Pregnancy-Monitoring System in One Northern and Two Southern Provinces in China between October 1, 1993, and September 30, 1995.). After the exclusion of pregnant women who were lost to follow-up or those for whom the status of the fetus or infant with respect to a neural-tube defect was unknown, there were 247,831 pregnant women, 31,960 in the northern region and 215,871 in the southern region (88 percent and 90 percent of all pregnant women, respectively) for whom the neural-tube–defect status of their fetus or infant was known. In both regions, the women who took folic acid pills were approximately two years younger than those who did not, were more likely to have registered before their last menstrual period, and were more likely to be pregnant for the first time (Table 2Table 2Characteristics of the Women for Whom the Status of the Fetus or Infant with Respect to a Neural-Tube Defect Was Known, According to Region and the Use of Folic Acid Pills.). In both regions the two groups were similar with respect to all other characteristics.Neural-Tube Defects
We identified 275 women who had a fetus or infant with a neural-tube defect: 112 in the northern region and 163 in the southern region. In both regions female fetuses or infants were more likely to be affected than male fetuses or infants (ratio of males to females, 1:1.6 in the northern region and 1:1.3 in the southern region). In the northern region, 47 percent of the neural-tube defects consisted of spina bifida, with anencephaly (20 percent) and craniorachischisis (21 percent) together accounting for 41 percent. In the southern region, 33 percent of the neural-tube defects consisted of spina bifida, with anencephaly (35 percent) and craniorachischisis (13 percent) accounting for 48 percent.
Use of Folic Acid Pills
The most common pattern of use was periconceptional use of folic acid pills in both the northern region (70 percent) and the southern region (53 percent) (Table 3Table 3
Rates of Neural-Tube Defects According to the Pattern of Use of Folic Acid Pills.). The rate of neural-tube defects was higher in the northern region than in the southern region, and within each region, it was lowest among the fetuses or infants of the women with periconceptional use of folic acid pills.Among the women who did not take any folic acid, the rates of neural-tube defects among fetuses or infants were 6.5 per 1000 pregnancies of at least 20 weeks' gestation in the northern region and 0.8 per 1000 pregnancies of at least 20 weeks' gestation in the southern region (Table 4Table 4
Rates and Risks of Neural-Tube Defects According to the Use of Folic Acid Pills.). Among the fetuses or infants of the women with any folic acid use, the respective rates were 1.3 and 0.7 per 1000 pregnancies of at least 20 weeks' gestation.The reduction in the risk of neural-tube defects among the fetuses or infants of the women who took folic acid (as compared with the fetuses or infants of women who did not take folic acid) was greater in the northern region (79 percent) than in the southern region (16 percent). In the northern region, the reduction in risk among the fetuses or infants of women with periconceptional use of folic acid was the same as that in the entire folic acid group (79 percent); in the southern region, however, the reduction in risk in this subgroup (41 percent) was larger than that for the group as a whole.
Among the fetuses or infants of women with periconceptional use who took folic acid more than 80 percent of the time, the reduction in risk was 85 percent in the northern region and 40 percent in the southern region. The rates of neural-tube defects were similar in these two subgroups (0.7 and 0.6 per 1000 pregnancies of at least 20 weeks' gestation, respectively) (Table 4). In the northern region, the risk of neural-tube defects in this subgroup was half that among fetuses or infants of the women who were compliant with the periconceptional use of folic acid no more than 80 percent of the time.
Discussion
We found that daily ingestion of 400 μg of folic acid alone during the periconceptional period reduced a woman's risk of having a fetus or infant with a neural-tube defect. This reduction occurred in an area of China in which the frequency of neural-tube defects is high and one in which it is low, and the magnitude of the reduction varied, depending on the base-line rate of neural-tube defects.
The strengths of our evaluation were that it was population-based, with nearly complete ascertainment of outcomes among large numbers of women whose pregnancies lasted at least 20 weeks, and that we prospectively documented the timing of the use of folic acid pills during the period of gestation within which neural-tube closure occurs, before the outcome of the pregnancy was known. Other strengths were the use of the system of prospective surveillance for birth defects, which was established before our evaluation began and identifies all affected fetuses and infants, and the establishment of diagnoses on the basis of photographs taken at birth and reviews of reports by several clinicians.
In this evaluation, women were not randomly selected to take or not to take folic acid pills. Therefore, the women who took them may have differed systematically from those who did not in factors that influence the frequency of neural-tube defects.14 Differences between the two groups in the numbers of women in whose fetuses birth defects were diagnosed prenatally and the rates of termination of pregnancies involving fetuses with neural-tube defects could result in differences in the rates of neural-tube defects, but prenatal diagnosis of birth defects is uncommon in all areas of China, and our surveillance system was designed to identify all affected fetuses. As compared with the women who took folic acid, those who did not were slightly older and were more likely to have been pregnant before. Stratification according to age and the number of previous pregnancies, however, did not change our results, nor did taking into account a woman's socioeconomic status (i.e., education and occupation).
In the southern region, the rates of neural-tube defects were lower among the fetuses or infants of women who took folic acid periconceptionally than among those of women who registered before their last menstrual period and who did not take any folic acid. Furthermore, in the northern region, higher rates of compliance (more than 80 percent) among the women who took folic acid periconceptionally were associated with a greater reduction in the frequency of neural-tube defects in their fetuses and infants, as compared with the women with lower rates of compliance. The fact that the ingestion of 400 μg of folic acid alone per day resulted in a reduction in risk similar to that reported in earlier studies,2-6,8 which evaluated the effect of folic acid in combination with multivitamins, suggests that most of the reduction in risk in the earlier studies was due to folic acid. However, our findings do not preclude the possibility that other vitamins or minerals may have an additional protective effect.
The difference in the rates of neural-tube defects between the northern region and the southern region was well documented by the comprehensive birth-defects surveillance system, which we established in January 1993. Because the use of folic acid pills began in October 1993, July 1994 was the first month in which full-term infants who had been exposed in utero to folic acid could have been born. This meant that there was an 18-month period when surveillance was conducted but there was no exposure, or only limited exposure, to folic acid among infants born between January 1993 and June 1994; during this period the base-line rate was 5.5 per 1000 births in the northern region and 1.0 per 1000 births in the southern region. During the period when the effects of folic acid should have been evident (July 1994 to December 1996), rates in the population as a whole (which included our study cohort) were 3.3 per 1000 births in the northern region and 0.8 per 1000 births in the southern region.
The difference in the base-line rates of neural-tube defects in the northern region and the southern region (which have similar, ethnically homogeneous populations) suggests that factors other than ethnic background may have a role in a woman's risk of having a fetus or infant with a neural-tube defect. Neither previously discussed potential risk factors (such as those shown in Table 2) nor differences in the rates of prenatal diagnosis of birth defects explain this regional difference. However, as a whole, the southern region (which is adjacent to Shanghai) is one of the wealthiest regions in China and has a more temperate climate with a longer growing season than the northern region. Whether these factors explain the regional difference in the rates of neural-tube defects is unclear. We were not able to collect information on the diets of the women or to determine whether there was a difference in diet between the northern region and the southern region. However, the fact that women with periconceptional ingestion of folic acid pills who were highly compliant in both the northern region and the southern region had similarly low rates of affected fetuses or infants suggests that the differences in background rates could be due in part to differences in dietary folic acid intake.
Neural-tube defects are a worldwide problem, affecting an estimated 300,000 or more fetuses or infants each year.15 Our results demonstrate that the ingestion of 400 μg of folic acid alone per day during the periconceptional period prevents neural-tube defects in areas of both high and low frequency. The higher rates in the northern region of China and the magnitude of the reduction there suggest that daily doses of folic acid of less than 4000 μg — the dose recommended by the Public Health Service for women with a previously affected fetus or infant 16 — may be effective in reducing risk in subsequent pregnancies, as others have also suggested.17,18 The preventive effect in the southern region of China, in which the base-line rate is similar to that in the United States and elsewhere,14 suggests that the daily ingestion of 400 μg of folic acid alone during the periconceptional period may help reduce the rate of the first occurrence of neural-tube defects in many parts of the world.
We are indebted to the thousands of health workers and village doctors whose dedication and effort made this project possible; to the Spina Bifida Association of America and the leaders of the Chinese Ministry of Health and Beijing Medical University (Chen Minzhang, Zhang Wenkang, Qin Xinhua, Peng Ruicong, Wang Debing, and Yan Renying), without whose support and assistance this project could not have been completed successfully; to the leaders of the Centers for Disease Control and Prevention (Godfrey P. Oakley, Jr., Richard J. Jackson, Steven B. Thacker, and the late Vernon Houk), without whose encouragement and support this project could never have been undertaken; to Brian J. McCarthy at the World Health Organization Collaborating Center in Perinatal Care in Atlanta, whose early work in China was the beginning; to Irene H. Yen, who was instrumental in establishing the project in Beijing; and to Yecai Liu for the development of surveillance software.
Source Information
From the Birth Defects and Genetic Diseases Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta (R.J.B., J.D.E., C.A.M., J.M., L.-Y.C.W., J.G., A.C.); and the National Center for Maternal and Infant Health and the Department of Health Care Epidemiology, Beijing Medical University, Beijing, China (Z.L., S.L., H.W., P.Z., S.-X.H.).
Address reprint requests to Dr. Berry at the Birth Defects and Genetic Diseases Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Hwy., MS F-45, Atlanta, GA 30341-3724.
Other participants in the China–U.S. Collaborative Project for Neural Tube Defect Prevention are listed in the Appendix.
Other authors were Ling Hao, M.D., M.P.H. (National Center for Maternal and Infant Health and the Department of Health Care Epidemiology, Beijing Medical University, Beijing, China), and Elaine Gunter, B.S., M.T.(A.S.C.P.) (Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta).
Appendix
The following persons participated in the China–U.S. Collaborative Project for Neural Tube Defect Prevention: Ministry of Health — Qin Xinhua, Shi Malin, Gu Shiguang, Shi Jiefang, Shi Anli, Liu Junli, Mu Yingying, Xu Lanfang, Li Zhongze; Beijing Medical University — Wang Debing, Ji Jingde, Lin Zhibin, Peng Ruicong, Yan Renying, He Guanqing (deceased), Qian Yuping (deceased), Liu Shijie, Li Tianlin, Li Kemin, Zhang Chao, Zhang Yansheng (deceased), Guan Yubei, Ye Rongwei, Liu Xiangdong, Xiong Zhaoxia, Gao Weixian, Zhang Qiaoyi, Tang Yi, Huhe Muren, Chen Yahua, Dai Guangsheng, Wang Long, Zhao Xiuqin, Zhang Li, Li Ting, Zhang Zefeng, Yang Wenhong, Lu Hongyu, Dao Jingjing, Qiu Yongtian, Shen Yanhui, Wang Mei, Wang Yuequn, Hu Yousheng, Hu Lin, Chen Hong, Chen Gang, Yuan Hongbo, Wang Zhonghong, Xu Xiaohui, Yin Zaidong, Zhu Huiping, Gu Zhihui, Gao Zhiping, Su Guanghui, Xiao Lan, Chen Xin, Chen Xing, Shen Liyang, He Lihua, Xiao Jun, Pei Lijun, Ji Chengye, Zheng Junchi, Zhao Rubing, Zhang Qing, Li Haojie, Wang Lina, Wang Yu, Liu Jianmeng, Gao Wanzhen, Liu Mingzhu, Liu Yan, Wang Jizhe, Li Nan, Liu Yanshu, Gu Haiqin, Li Kewei, Li Yong, Hu Yuanhua, Bao Yueqin, Li Wanzhen, Ma Yuwen, Wang Linhong, Wang Taimei, Zhao Gengli, Chen Lijun, Lin Qing, Zhang Wei, Sun Shanggong, Qu Chuanyan, Zhao Fenglin, Bai Zhi, Li Ying, Lu Qinghao, Wang Puyu, Wang Qiaoqiao, Liu Yanfei, Li Fengning; Hebei Province — Wang Youhui, Yang Qian, Duan Li, Wang Liren, Li Hongying, Zhao Yan, Chen Xunzhao, Feng Guoan, Zhang Mingqing, Fan Fusheng, Ran Dewang, Shi Congyi, Sun Aiying, Sun Chenyan, Tian Wenrui, Liang Guowen, Zhao Yurong, Liu Tianen, Liu Weihe, Wang Wenxiu, Jia Limin, Jing Rui, Tian Junfeng, Zhang Xueqin, Tian Gengzhi, Li Changlin, Xin Cuizhi, Hu Wei, Ma Jie; Mancheng County: Lu Wenzhan, Yao Xiuzhi, Liu Zhixin (deceased), Zhang Shufen; Shijiazhuang City: Zhang Chenglu, Li Jefen, Xie Lianyun; Yuanshi County: He Huandai, Hu Xiaomei, Jia Wenfang; Fengrun County: Du Bing, Yue Chunxiang, Hou Guangwang; Laoting County: Yin Shufen, Zhao Surong, Cai Yunzong, Wang Xianglin; Langfang City: Zhu Liwen; Xianghe County: Shi Wenzhi, Du Weiyan, Yao Xiaoyun; Shanxi Province — Wang Zhifang, Li Ruiyu, Yang Yushu, Sun Shizhang, Hao Shengfang, Pan Yuying, Gao Fengju, Sheng Shucai, Li Shuangting, Jia Li; Fenyang County: Zhang Guozhong; Taiyuan Nancheng: Liu Yuee; Zhejiang Province — Zhuang Bingjin, Zhou Kun, Fan Baling, Kang Mingdao, Zhou Aizhen, Zhang Guohua, Shen Jiaxian, Shen Rongde, Zhang Menghua, Jin Shifang, Chen Xingya; Jiaxing City: Mu Huiyuan, Yang Dongping, Jiang Yanying, Tong Qiaoling, Chen Hua; Jiashan County: Jiang Lianfu, Chen Yuyuan, Xie Quanying; Jiaxing County: Chen Meiying, Chen Duofei, Qian Yingming; Haiyan County: Ling Jingeng, Ba Disheng, Pan Yujuan, Fei Minjuan; Pinghu City: Feng Meixian, Zhang Taihua, Wu Limin; Tongxiang City: Xu Yifen, Chen Minqiang, Chen Hao; Haining City: Yao Shuiyin, Gao Yuelin, Sun Xiamei; Ningbo City: Ling Guolian, Zhu Yuanqing, Zhou Minggao (deceased), Chen Yanyu; Cixi City: Chen Jiguang, Shi Boyao, Wang Qiaohua; Fenghua City: Liu Rongjiao, Xia Pinguo, Wang Haiming; Yin County: He Changhui, Yu Cuilin, Jin Lingui; Ninghai County: Zhu Shuidi, Yang Xianming, Wang Jiamei; Zhoushan City: Wang Shihe, Yang Erchang, Zhou Qingxin; Jiangsu Province — Chen Ping, Chen Hao, Wang Zhuping, Zhou Dayan, Zhou Mingqi, He Shuxiang, Chen Xiaohui, Yang Jianxiong, Fu Caiqin, Pu Shaotang, Zhang Yingzhong, Zhu Xingyuan, Zhou Yonglan, Zhang Menglan, Zhao Nengxiu, Wang Xuelin, Pan Zhongyue, Xu Chongjia, Xu Haifeng, Zhang Ying, Zheng Yinlin, Chen Zhong, Jiang Zhongliang, Tang Yaogen, Wu Xuansheng, Zhao Gongtai, Jiang Jiongyuan; Suzhou City: Zhu Yongxin, Jiang Meifang; Kunshan City: Shao Peiyuan; Taicang City: Chen Huifang, Zhou Caiping, Zhang Menglan; Wujiang City: Tang Jianfang; Wu County: Yang Xiaoling; Wuxi City: Zhang Huaixi, Chen Yafen, Zhu Wenyu; Xishan City: Shen Quanzhen; Jiangyin City: Xu Jiafu.
- References
References
1
Smithells RW ,Sheppard S ,Schorah CJ , et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-340
CrossRef | Web of Science | Medline2
Mulinare J ,Cordero JF ,Erickson JD ,Berry RJ . Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-3145
CrossRef | Web of Science | Medline3
Milunsky A ,Jick H ,Jick SS , et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852
CrossRef | Web of Science | Medline4
Bower C ,Stanley FJ . Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-619
Web of Science | Medline5
Werler MM ,Shapiro S ,Mitchell AA . Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-1261
CrossRef | Web of Science | Medline6
Shaw GM ,Schaffer D ,Velie EM ,Morland K ,Harris JA . Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects in California. Epidemiology 1995;6:219-226
CrossRef | Web of Science | Medline7
MRC Vitamin Study Research Group
CrossRef | Web of Science | Medline8
Czeizel AE ,Dudas I . Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835
Full Text | Web of Science | Medline9
Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defectsMMWR Morb Mortal Wkly Rep 1992;41:1-7
Medline10
Cornel MC ,Erickson JD . Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 1997;55:134-137
CrossRef | Medline11
Xiao KZ ,Zhang ZY ,Su YM , et al. Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese Birth Defects Monitoring Program. Int J Epidemiol 1990;19:978-982
CrossRef | Web of Science | Medline12
Moore CA ,Li S ,Li Z , et al. Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Genet 1997;73:113-118
CrossRef | Web of Science | Medline13
SAS/STAT software: changes and enhancements through release 6.12. Cary, N.C.: SAS Institute, 1997.
14
Olney R ,Mulinare J . Epidemiology of neural tube defects. Ment Retard Dev Disabil Res Rev 1998;4:241-246
CrossRef | Web of Science15
Murray CJL, Lopez AD, eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Vol. 1 of Global burden of disease and injury series. Cambridge, Mass.: Harvard School of Public Health, 1996.
16
Use of folic acid for prevention of spina bifida and other neural tube defects -- 1983-1991MMWR Morb Mortal Wkly Rep 1991;40:513-516
Medline17
Smithells RW ,Nevin NC ,Seller MJ , et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1:1027-1031
CrossRef | Web of Science | Medline18
Kirke PN ,Daly LE ,Elwood JH . A randomized trial of low dose folic acid to prevent neural tube defects. Arch Dis Child 1992;67:1442-1446
CrossRef | Web of Science | Medline
- Citing Articles (329)
Citing Articles
1
Lars H. Breimer, Torbjörn K. Nilsson. (2012) Has folate a role in the developing nervous system after birth and not just during embryogenesis and gestation?. Scandinavian Journal of Clinical & Laboratory Investigation1-7
CrossRef2
Priscilla A. Zetstra-van der Woude, Hermien E.K. de Walle, Lolkje T.W. de Jong-van den Berg. (2012) Periconceptional folic acid use: Still room to improve. Birth Defects Research Part A: Clinical and Molecular Teratologyn/a-n/a
CrossRef3
Xiaoping Liang, Yong Wang, Qiong Lin Liang, Yi Ming Wang, Min Huang, Guoan Luo. (2011) Pathogenesis of neural tube defects: the story beyond methylation or one-carbon unit metabolism. Metabolomics
CrossRef4
Kelly R. S. Fehr, Kelsey D. H. Fehr, Jennifer Lisa Penner Protudjer. (2011) Knowledge and Use of Folic Acid in Women of Reproductive Age. Canadian Journal of Dietetic Practice and Research 72:4, 197-200
CrossRef5
Xi W. Wang, Ya L. Luo, Wei Wang, Yu Zhang, Qing Chen, Yu L. Cheng. (2011) Association between MTHFR A1298C polymorphism and neural tube defect susceptibility: a metaanalysis. American Journal of Obstetrics and Gynecology
CrossRef6
Bëngt Källén. 2011. Human studies—Epidemiologic techniques in developmental and reproductive toxicology. , 643-674.
CrossRef7
Hua Xie, Jin Guo, Jianhua Wang, Fang Wang, Huizhi Zhao, Chi Liu, Li Wang, Xiaolin Lu, Lihua Wu, Yihua Bao, Jizhen Zou, Ting Zhang, Bo Niu. (2011) Glutamate carboxypeptidase II gene polymorphisms and neural tube defects in a high-risk Chinese population. Metabolic Brain Disease
CrossRef8
Mingming Su, Xiao Ying Zheng, Ting Zhang, Lijun Pei, Fang Wang, Xiaojiao Zheng, Xue Gu, Xinming Song, Xiaolin Lu, Gong Chen, Yihua Bao, Tianlu Chen, Aihua Zhao, Yuqian Bao, Wei Ping Jia, Steven H. Zeisel, Wei Jia. (2011) Integrated profiling of metabolites and trace elements reveals a multifaceted malnutrition in pregnant women from a region with a high prevalence of congenital malformations. Metabolomics
CrossRef9
Yunni Yi, Marion Lindemann, Antje Colligs, Claire Snowball. (2011) Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. European Journal of Pediatrics 170:11, 1391-1400
CrossRef10
Xiaoying Zheng, Mingming Su, Lijun Pei, Ting Zhang, Xu Ma, Yunping Qiu, Hongfei Xia, Fang Wang, Xiaojiao Zheng, Xue Gu, Xinming Song, Xin Li, Xin Qi, Gong Chen, Yihua Bao, Tianlu Chen, Yi Chi, Aihua Zhao, Wei Jia. (2011) Metabolic Signature of Pregnant Women with Neural Tube Defects in Offspring. Journal of Proteome Research 10:10, 4845-4854
CrossRef11
Xiu-Ya Xing, Fang-Biao Tao, Jia-Hu Hao, Kun Huang, Zhao-Hui Huang, Xiao-Ming Zhu, Li-Min Xiao, Dai-Juan Cheng, Pu-Yu Su, Peng Zhu, Yuan-Yuan Xu, Ying Sun. (2011) Periconceptional folic acid supplementation among women attending antenatal clinic in Anhui, China: Data from a population-based cohort study. Midwifery
CrossRef12
Ting Wang, Jun Zhang, Xinrong Lu, Wei Xi, Zhu Li. (2011) Maternal early pregnancy body mass index and risk of preterm birth. Archives of Gynecology and Obstetrics 284:4, 813-819
CrossRef13
Stephanie MC Wilson, Brittney N Bivins, Katelyn A Russell, Lynn B Bailey. (2011) Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status. Nutrition Reviews 69:10, 572-583
CrossRef14
R. L. Brent. (2011) The Role of the Pediatrician in Preventing Congenital Malformations. Pediatrics in Review 32:10, 411-422
CrossRef15
Suzanne M. Gilboa, Cheryl S. Broussard, Owen J. Devine, Kara N. Duwe, Audrey L. Flak, Sheree L. Boulet, Cynthia A. Moore, Martha M. Werler, Margaret A. Honein. (2011) Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 157:3, 234-246
CrossRef16
A. L. Boyles, J. L. Ballard, E. B. Gorman, D. R. McConnaughey, R. M. Cabrera, A. J. Wilcox, R. T. Lie, R. H. Finnell. (2011) Association between inhibited binding of folic acid to folate receptor in maternal serum and folate-related birth defects in Norway. Human Reproduction 26:8, 2232-2238
CrossRef17
D. Rofail, A. Colligs, L. Abetz, M. Lindemann, L. Maguire. (2011) Factors contributing to the success of folic acid public health campaigns. Journal of Public Health
CrossRef18
Rongwei Ye, Aiguo Ren, Le Zhang, Zhiwen Li, Jianmeng Liu, Lijun Pei, Xiaoying Zheng. (2011) Tea Drinking as a Risk Factor for Neural Tube Defects in Northern China. Epidemiology 22:4, 491-496
CrossRef19
Pierpaolo Mastroiacovo, Emanuele Leoncini. (2011) More folic acid, the five questions: Why, who, when, how much, and how. BioFactors 37:4, 272-279
CrossRef20
Stephan Bart, Joachim Marr, Konstanze Diefenbach, Dietmar Trummer, Carole Sampson-Landers. (2011) Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception
CrossRef21
Marit P. Martinussen, Kari R. Risnes, Geir W. Jacobsen, Michael B. Bracken. (2011) Folic acid supplementation in early pregnancy and asthma in children aged 6 years. American Journal of Obstetrics and Gynecology
CrossRef22
M. Laanpere, S. Altmäe, T. Kaart, A. Stavreus-Evers, T.K. Nilsson, A. Salumets. (2011) Folate-metabolizing gene variants and pregnancy outcome of IVF. Reproductive BioMedicine Online 22:6, 603-614
CrossRef23
Pei-Pei Song, Yi Hu, Chun-Mei Liu, Mu-Ju Yan, Ge Song, Yi Cui, Hong-Fei Xia, Xu Ma. (2011) Embryonic ectoderm development protein is regulated by microRNAs in human neural tube defects. American Journal of Obstetrics and Gynecology 204:6, 544.e9-544.e17
CrossRef24
Yinghui Liu, Jun Zhang, Zhu Li. (2011) Perinatal outcomes in native Chinese and Chinese-American women. Paediatric and Perinatal Epidemiology 25:3, 202-209
CrossRef25
Judith Lumley, Lyndsey Watson, Max Watson, Carol Bower, Judith Lumley. 2011. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. .
CrossRef26
Bob Wilffert, Judith Altena, Laurien Tijink, Marleen MHJ van Gelder, Lolkje TW de Jong-van den Berg. (2011) Pharmacogenetics of drug-induced birth defects: what is known so far?. Pharmacogenomics 12:4, 547-558
CrossRef27
R. H. de Groot, A. D. Stein, J. Jolles, M. P. van Boxtel, G.-J. Blauw, M. van de Bor, L. Lumey. (2011) Prenatal famine exposure and cognition at age 59 years. International Journal of Epidemiology 40:2, 327-337
CrossRef28
Cornelia M. Witthöft. 2011. Analytical Methods to Assess the Bioavailability of Water-Soluble Vitamins in Food-Exemplified by Folate. , 21-36.
CrossRef29
Ronald G. Munger, Tsunenobu Tamura, Kelley E. Johnston, Marcia L. Feldkamp, Roxane Pfister, Richard Cutler, Maureen A. Murtaugh, John C. Carey. (2011) Oral clefts and maternal biomarkers of folate-dependent one-carbon metabolism in utah. Birth Defects Research Part A: Clinical and Molecular Teratology 91:3, 153-161
CrossRef30
Claude Stoll, Beatrice Dott, Yves Alembik, Marie-Paule Roth. (2011) Associated malformations among infants with neural tube defects. American Journal of Medical Genetics Part A 155:3, 565-568
CrossRef31
Mario A. Cleves, Charlotte A. Hobbs, Weizhi Zhao, Patrycja A. Krakowiak, Stewart L. MacLeod, . (2011) Association between selected folate pathway polymorphisms and nonsyndromic limb reduction defects: a case-parental analysis. Paediatric and Perinatal Epidemiology 25:2, 124-134
CrossRef32
Tony Sheehy, Sangita Sharma. (2011) Use of FAO food balance sheets to estimate the potential ability of novel folate-enriched eggs to increase the folate supply in European Union countries. Public Health Nutrition 14:03, 551-556
CrossRef33
Atsuo Kondo, Yoshimasa Asada, Kanemitsu Shibata, Masamichi Kihira, Keiu Ninomiya, Masatoshi Suzuki, Hidenori Oguchi, Yoshihiko Hayashi, Osamu Narita, Junichiro Watanabe, Yoichi Shimosuka. (2011) Dietary folate intakes and effects of folic acid supplementation on folate concentrations among Japanese pregnant women. Journal of Obstetrics and Gynaecology Researchno-no
CrossRef34
Guido Filler, Mireille Gharib, Shelley Casier, Petra Lödige, Jochen H. H. Ehrich, Sumit Dave. (2011) Prevention of chronic kidney disease in spina bifida. International Urology and Nephrology
CrossRef35
Claudine Nasr Hage, Maya Jalloul, Mohamad Sabbah, Salim M. Adib. (2011) Awareness and Intake of Folic Acid for the Prevention of Neural Tube Defects Among Lebanese Women of Childbearing Age. Maternal and Child Health Journal
CrossRef36
Dorte Clemmensen, Mathias Thygesen, Mikkel Mylius Rasmussen, Morten Fenger-Grøn, Olav B. Petersen, Claus Mosdal. (2011) Decreased incidence of myelomeningocele at birth: effect of folic acid recommendations or prenatal diagnostics?. Child s Nervous System
CrossRef37
Jana Behunova, Lucia Klimcakova, Ludmila Podracka. (2011) Urinary Tract Anomalies Associated with MTHFR Gene Polymorphism C677T in Girls. Kidney and Blood Pressure Research 34:6, 465-471
CrossRef38
Brett T. Chiquet, Robin Henry, Amber Burt, John B. Mulliken, Samuel Stal, Susan H. Blanton, Jacqueline T. Hecht. (2011) Nonsyndromic cleft lip and palate: CRISPLD genes and the folate gene pathway connection. Birth Defects Research Part A: Clinical and Molecular Teratology 91:1, 44-49
CrossRef39
Ferenc Bánhidy, Nándor Ács, Erzsébet H Puhó, Andrew E Czeizel. (2011) Hypotension in pregnant women: a population-based case–control study of pregnancy complications and birth outcomes. Hypertension Research 34:1, 55-61
CrossRef40
Nikhil Shelke, Louis Keith. (2011) Folic Acid Supplementation for Women of Childbearing Age versus Supplementation for the General Population: A Review of the Known Advantages and Risks. International Journal of Family Medicine 2011, 1-4
CrossRef41
Aamer Imdad, Mohammad Yawar Yakoob, Zulfiqar A Bhutta. (2011) The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths. BMC Public Health 11:Suppl 3, S4
CrossRef42
Mohamed A. Baraka, Stephane Steurbaut, Liesbeth Leemans, Walter Foulon, Monika Laubach, Danny Coomans, Eleonora Jansen, Alain G. Dupont. (2011) Determinants of folic acid use in a multi-ethnic population of pregnant women: a cross-sectional study. Journal of Perinatal Medicine-
CrossRef43
Tony Sheehy, Sangita Sharma. (2011) The nutrition transition in the Republic of Ireland: trends in energy and nutrient supply from 1961 to 2007 using Food and Agriculture Organization food balance sheets. British Journal of Nutrition1
CrossRef44
Yanyu Lu, Jun Zhang, Xinrong Lu, Wei Xi, Zhu Li. (2011) Secular trends of macrosomia in southeast China, 1994-2005. BMC Public Health 11:1, 818
CrossRef45
Sophia Xue, Xingqian Ye, John Shi, Yueming Jiang, Donghong Liu, Jianchu Chen, Andy Shi, Yukio Kakuda. (2011) Degradation kinetics of folate (5-methyltetrahydrofolate) in navy beans under various processing conditions. LWT - Food Science and Technology 44:1, 231-238
CrossRef46
Andrew E. Czeizel, István Dudás, László Paput, Ferenc Bánhidy. (2011) Prevention of Neural-Tube Defects with Periconceptional Folic Acid, Methylfolate, or Multivitamins?. Annals of Nutrition and Metabolism 58:4, 263-271
CrossRef47
Chandra S. Mayanil, Shunsuke Ichi, Barbara-Mania Farnell, Vanda Boshnjaku, Tadanori Tomita, David G. McLone. 2011. Maternal Intake of Folic Acid and Neural Crest Stem Cells. , 143-173.
CrossRef48
Helmut Heseker. (2011) Folic Acid and Other Potential Measures in the Prevention of Neural Tube Defects. Annals of Nutrition and Metabolism 59:1, 41-45
CrossRef49
Andrew E. Czeizel. (2011) Periconceptional Folic Acid-Containing Multivitamin Supplementation for the Prevention of Neural Tube Defects and Cardiovascular Malformations. Annals of Nutrition and Metabolism 59:1, 38-40
CrossRef50
John Scott. (2011) Folic Acid Consumption throughout Pregnancy – Differentiation between Trimesters. Annals of Nutrition and Metabolism 59:1, 46-49
CrossRef51
Davide Agnoletti, Yi Zhang, Sébastien Czernichow, Pilar Galan, Serge Hercberg, Michel E. Safar, Jacques Blacher. 2011. Fortification of Vitamin B12 to Flour and the Metabolic Response. , 437-449.
CrossRef52
W. Zeng, L. Liu, Y. Tong, H.M. Liu, L. Dai, M. Mao. (2011) A66G and C524T polymorphisms of the methionine synthase reductase gene are associated with congenital heart defects in the Chinese Han population. Genetics and Molecular Research 10:4, 2597-2605
CrossRef53
C. Huang, Z. Li, K. M. Venkat Narayan, D. F. Williamson, R. Martorell. (2010) Bigger babies born to women survivors of the 1959–1961 Chinese famine: a puzzle due to survival selection?. Journal of Developmental Origins of Health and Disease 1:06, 412-418
CrossRef54
Michelle R O'Byrne, Kit Sing Au, Hope Northrup. 2010. Neural Tube Defects: Genetics. .
CrossRef55
Chen Ma, Suzan L. Carmichael, Angela E. Scheuerle, Mark A. Canfield, Gary M. Shaw. (2010) Association of microtia with maternal obesity and periconceptional folic acid use. American Journal of Medical Genetics Part A 152A:11, 2756-2761
CrossRef56
Erika Erős, Anett Hajós. (2010) A családtervezés Magyarországon: múlt és jelen. Orvosi Hetilap 151:45, 1858-1862
CrossRef57
Mayuree Soongsongkiat, Prapasri Puwastien, Sitima Jittinandana, Angkansiri Dee-Uam, Pongtorn Sungpuag. (2010) Testing of folate conjugase from chicken pancreas vs. commercial enzyme and studying the effect of cooking on folate retention in Thai foods. Journal of Food Composition and Analysis 23:7, 681-688
CrossRef58
Luz Maria De-Regil, Ana C Fernández-Gaxiola, Therese Dowswell, Juan Pablo Peña-Rosas, Luz Maria De-Regil. 2010. Effects and safety of periconceptional folate supplementation for preventing birth defects. .
CrossRef59
Suzan L. Carmichael, Sonja A. Rasmussen, Gary M. Shaw. (2010) Prepregnancy obesity: A complex risk factor for selected birth defects. Birth Defects Research Part A: Clinical and Molecular Teratology 88:10, 804-810
CrossRef60
Ferenc Bánhidy, Abdallah Dakhlaoui, Erzsébet H. Puhó, Andrew A. E. Czeizel. (2010) Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation?. Congenital Anomaliesno-no
CrossRef61
Lei Jin, Lorraine F Yeung, Mary E Cogswell, Rongwei Ye, Robert J Berry, Jianmeng Liu, Dale J Hu, Li Zhu. (2010) Prevalence of anaemia among pregnant women in south-east China, 1993–2005. Public Health Nutrition 13:10, 1511-1518
CrossRef62
Ziqian Zeng, Jun Zhu. (2010) Low folic acid supplement intake rate among women in northern China with a high-prevalence of neural tube defects, 2008. Preventive Medicine 51:3-4, 338-339
CrossRef63
Carolyn M. Summers, Laura E. Mitchell, Anna Stanislawska-Sachadyn, Shirley F. Baido, Ian A. Blair, Joan M. Von Feldt, Alexander S. Whitehead. (2010) Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. Birth Defects Research Part A: Clinical and Molecular Teratology 88:8, 679-688
CrossRef64
Adrian D. Sandler. (2010) Children with Spina Bifida: Key Clinical Issues. Pediatric Clinics of North America 57:4, 879-892
CrossRef65
Suzan L. Carmichael, Wei Yang, Gary M. Shaw. (2010) Periconceptional nutrient intakes and risks of neural tube defects in California. Birth Defects Research Part A: Clinical and Molecular Teratology 88:8, 670-678
CrossRef66
Philip J. Lupo, Elaine Symanski, D. Kim Waller, Wenyaw Chan, Mark A. Canfield, Peter H. Langlois, Laura E. Mitchell. (2010) Polytomous logistic regression as a tool for exploring heterogeneity across birth defect subtypes: An example using anencephaly and spina bifida. Birth Defects Research Part A: Clinical and Molecular Teratology 88:8, 701-705
CrossRef67
Jana Behunova, Lucia Klimcakova, Eva Zavadilikova, Dana Potocekova, Pavol Sykora, Ludmila Podracka. (2010) Methylenetetrahydrofolate reductase gene polymorphisms and neural tube defects epidemiology in the Slovak population. Birth Defects Research Part A: Clinical and Molecular Teratology 88:8, 695-700
CrossRef68
DHANYA GANGADHARAN, SWETHA SIVARAMAKRISHNAN, ASHOK PANDEY, KESAVAN MADHAVAN NAMPOOTHIRI. (2010) Folate-producing lactic acid bacteria from cow’s milk with probiotic characteristics. International Journal of Dairy Technology 63:3, 339-348
CrossRef69
M. Elizabeth Ross. (2010) Gene-environment interactions, folate metabolism and the embryonic nervous system. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2:4, 471-480
CrossRef70
Amos Olufemi Adeleye, Magbagbeola D. Dairo, Kayode G. Olowookere. (2010) Central nervous system congenital malformations in a developing country: issues and challenges against their prevention. Child's Nervous System 26:7, 919-924
CrossRef71
Mehmet Mutlu, Beril Dilber, Yakup Aslan. (2010) Cornelia de Lange syndrome associated with thoracic meningocele. Clinical Dysmorphology 19:3, 161-163
CrossRef72
Mohammed Hefni, Veronica Öhrvik, Mohamed Tabekha, Cornelia Witthöft. (2010) Folate content in foods commonly consumed in Egypt. Food Chemistry 121:2, 540-545
CrossRef73
Xiaoli Chen, Jin Guo, Yunping Lei, Jizhen Zou, Xiaolin Lu, Yihua Bao, Lihua Wu, Jianxin Wu, Xiaoying Zheng, Yiping Shen, Bai-Lin Wu, Ting Zhang. (2010) Global DNA hypomethylation is associated with NTD-affected pregnancy: A case-control study. Birth Defects Research Part A: Clinical and Molecular Teratology 88:7, 575-581
CrossRef74
Hans De Steur, Xavier Gellynck, Sergei Storozhenko, Ge Liqun, Willy Lambert, Dominique Van Der Straeten, Jacques Viaene. (2010) Health impact in China of folate-biofortified rice. Nature Biotechnology 28:6, 554-556
CrossRef75
Sarah C. Tinker, Mary E. Cogswell, Owen Devine, Robert J. Berry. (2010) Folic Acid Intake Among U.S. Women Aged 15–44 Years, National Health and Nutrition Examination Survey, 2003–2006. American Journal of Preventive Medicine 38:5, 534-542
CrossRef76
Godfrey P. Oakley. (2010) Folic Acid–Preventable Spina Bifida. American Journal of Preventive Medicine 38:5, 569-570
CrossRef77
H. Blencowe, S. Cousens, B. Modell, J. Lawn. (2010) Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology 39:Supplement 1, i110-i121
CrossRef78
JiangHui Zhu, Ling Hao, Song Li, Lynn B. Bailey, YiHua Tian, Zhu Li. (2010) MTHFR , TGFB3 , and TGFA polymorphisms and their association with the risk of non-syndromic cleft lip and cleft palate in China. American Journal of Medical Genetics Part A 152A:2, 291-298
CrossRef79
H. De Steur, X. Gellynck, S. Storozhenko, G. Liqun, W. Lambert, D. Van Der Straeten, J. Viaene. (2010) Willingness-to-accept and purchase genetically modified rice with high folate content in Shanxi Province, China. Appetite 54:1, 118-125
CrossRef80
M. McGuire, B. Cleary, L. Sahm, D.J. Murphy. (2010) Prevalence and predictors of periconceptional folic acid uptake--prospective cohort study in an Irish urban obstetric population. Human Reproduction 25:2, 535-543
CrossRef81
A.E. Czeizel, E.H. Puhó, Z. Langmar, N. Ács, F. Bánhidy. (2010) Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. European Journal of Obstetrics & Gynecology and Reproductive Biology 148:2, 135-140
CrossRef82
GL Wehby, JC Murray. (2010) Folic acid and orofacial clefts: a review of the evidence. Oral Diseases 16:1, 11-19
CrossRef83
Anthony Fardet. (2010) New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?. Nutrition Research Reviews 23:1, 65
CrossRef84
Jin‐Feng Wang, Xin‐Hu Li, George Christakos, Yi‐Lan Liao, Tin Zhang, Xue Gu, Xiao‐Ying Zheng. (2010) Geographical Detectors‐Based Health Risk Assessment and its Application in the Neural Tube Defects Study of the Heshun Region, China. International Journal of Geographical Information Science 24:1, 107-127
CrossRef85
John M. DeSesso, Calvin C. Willhite. 2009. Developmental Toxicology. .
CrossRef86
Ilan Matok, Rafael Gorodischer, Gideon Koren, Daniella Landau, Arnon Wiznitzer, Amalia Levy. (2009) Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. British Journal of Clinical Pharmacology 68:6, 956-962
CrossRef87
Igor Medica, Ales Maver, Goncalo Figueiredo Augusto, Borut Peterlin. (2009) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome — meta-analysis. Central European Journal of Medicine 4:4, 395-408
CrossRef88
Charlotte Hobbs, Gary Shaw, Martha Werler, Bridget Mosley. 2009. Folate Status and Birth Defect Risk. , 133-153.
CrossRef89
Robert Berry, Joseph Mulinare, Heather Hamner. 2009. Folic Acid Fortification. , 179-204.
CrossRef90
Siobhan M. Dolan, William M. Callaghan, Sonja A. Rasmussen. (2009) Birth defects and preterm birth: Overlapping outcomes with a shared strategy for research and prevention. Birth Defects Research Part A: Clinical and Molecular Teratology 85:11, 874-878
CrossRef91
Julianne S. Collins, Mark A. Canfield, Kay Pearson, Russell S. Kirby, Amy P. Case, Cara T. Mai, Judy Major, Joe Mulinare, . (2009) Public health projects for preventing the recurrence of neural tube defects in the United States. Birth Defects Research Part A: Clinical and Molecular Teratology 85:11, 935-938
CrossRef92
Qiaoyi Zhang, Cande V. Ananth, George G. Rhoads, Zhu Li. (2009) The Impact of Maternal Anemia on Perinatal Mortality: A Population-based, Prospective Cohort Study in China. Annals of Epidemiology 19:11, 793-799
CrossRef93
Q. Zhang, C. V Ananth, Z. Li, J. C Smulian. (2009) Maternal anaemia and preterm birth: a prospective cohort study. International Journal of Epidemiology 38:5, 1380-1389
CrossRef94
Carla A. Martinez, Hope Northrup, Jone-Ing Lin, Alanna C. Morrison, Jack M. Fletcher, Gayle H. Tyerman, Kit Sing Au. (2009) Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida. American Journal of Obstetrics and Gynecology 201:4, 394.e1-394.e11
CrossRef95
Lijun Pei, Jianmeng Liu, Yewu Zhang, Huiping Zhu, Aiguo Ren. (2009) Association of reduced folate carrier gene polymorphism and maternal folic acid use with neural tube defects. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B:6, 874-878
CrossRef96
Y Wang, E Gao, J Wu, J Zhou, Q Yang, M C Walker, M Mbikay, R J Sigal, R C Nair, S W Wen. (2009) Fetal macrosomia and adolescence obesity: results from a longitudinal cohort study. International Journal of Obesity 33:8, 923-928
CrossRef97
Andreu Palou, Catalina Pico, Jaap Keijer. (2009) Integration of Risk and Benefit Analysis—The Window of Benefit as a New Tool?. Critical Reviews in Food Science and Nutrition 49:7, 670-680
CrossRef98
Jean Golding. (2009) Who should be studied and when in a longitudinal birth cohort?. Paediatric and Perinatal Epidemiology 23, 15-22
CrossRef99
Jean Golding, Colin Steer. (2009) How many subjects are needed in a longitudinal birth cohort study?. Paediatric and Perinatal Epidemiology 23, 31-38
CrossRef100
Vu Thi Thu Hien, Nguyen Thi Lam, Nguyen Cong Khan, Nguyen Tri Dung, C Murray Skeaff, Bernard J Venn, Trevor Walmsley, Peter M George, Judy McLean, Matthew R Brown, Timothy J Green. (2009) Folate and vitamin B12 status of women of reproductive age living in Hanoi City and Hai Duong Province of Vietnam. Public Health Nutrition 12:07, 941
CrossRef101
Qiaoyi Zhang, Zhu Li, Cande V. Ananth. (2009) Prevalence and risk factors for anaemia in pregnant women: a population-based prospective cohort study in China. Paediatric and Perinatal Epidemiology 23:4, 282-291
CrossRef102
R. Hasan, A. F. Olshan, A. H. Herring, D. A. Savitz, A. M. Siega-Riz, K. E. Hartmann. (2009) Self-reported Vitamin Supplementation in Early Pregnancy and Risk of Miscarriage. American Journal of Epidemiology 169:11, 1312-1318
CrossRef103
Mark A Lawrence, Weizhong Chai, Raija Kara, Irwin H Rosenberg, John Scott, Alison Tedstone. (2009) Examination of selected national policies towards mandatory folic acid fortification. Nutrition Reviews 67, S73-S78
CrossRef104
H Tamim, G Harrison, M Atoui, G Mumtaz, F El-Kak, M Seoud, K Yunis, . (2009) Preconceptional folic acid supplement use in Lebanon. Public Health Nutrition 12:05, 687
CrossRef105
Hee-Kyung Jeon, Youn-Jung Kim, Jae-Chun Ryu. (2009) Preparation of folic acid-chitosan complex (eco-yellow) and its application for adsorption of mutagens and carcinogens. Toxicology and Environmental Health Sciences 1:1, 64-68
CrossRef106
H Zhu, S Kartiko, RH Finnell. (2009) Importance of gene-environment interactions in the etiology of selected birth defects. Clinical Genetics 75:5, 409-423
CrossRef107
Yaling Zhao, Ling Hao, Le Zhang, Yihua Tian, Yiwu Cao, Haihui Xia, Yajun Deng, Tiangui Wang, Ming Yu, Zhu Li. (2009) Plasma folate status and dietary folate intake among Chinese women of childbearing age. Maternal & Child Nutrition 5:2, 104-116
CrossRef108
Anne M. Molloy, Lawrence C. Brody, James L. Mills, John M. Scott, Peadar N. Kirke. (2009) The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Research Part A: Clinical and Molecular Teratology 85:4, 285-294
CrossRef109
Andrew E. Czeizel. (2009) Periconceptional folic acid and multivitamin supplementation for the prevention of neural tube defects and other congenital abnormalities. Birth Defects Research Part A: Clinical and Molecular Teratology 85:4, 260-268
CrossRef110
Muriel J. Harris. (2009) Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants. Birth Defects Research Part A: Clinical and Molecular Teratology 85:4, 331-339
CrossRef111
L. Brough, G. A. Rees, M. A. Crawford, E. K. Dorman. (2009) Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status. Journal of Human Nutrition and Dietetics 22:2, 100-107
CrossRef112
Godfrey P. Oakley. (2009) The Scientific Basis for Eliminating Folic Acid–Preventable Spina Bifida: A Modern Miracle from Epidemiology. Annals of Epidemiology 19:4, 226-230
CrossRef113
Omar Dary. (2009) Nutritional interpretation of folic acid interventions. Nutrition Reviews 67:4, 235-244
CrossRef114
Margaret A. Honein, Russell S. Kirby, Robert E. Meyer, Jian Xing, Nyasha I. Skerrette, Nataliya Yuskiv, Lisa Marengo, Joann R. Petrini, Michael J. Davidoff, Cara T. Mai, Charlotte M. Druschel, Samara Viner-Brown, Lowell E. Sever, . (2009) The Association Between Major Birth Defects and Preterm Birth. Maternal and Child Health Journal 13:2, 164-175
CrossRef115
Daria Cipollone, Rita Carsetti, Angela Tagliani, Maria Manuela Rosado, Paola Borgiani, Giuseppe Novelli, Giulia D'Amati, Lorenzo Fumagalli, Bruno Marino, Rita Businaro. (2009) Folic acid and methionine in the prevention of teratogen-induced congenital defects in mice. Cardiovascular Pathology 18:2, 100-109
CrossRef116
Shu Wen, Wei Lu, Huiping Zhu, Wei Yang, Gary M. Shaw, Edward J. Lammer, Ana Islam, Richard H. Finnell. (2009) Genetic polymorphisms in the thioredoxin 2 ( TXN2 ) gene and risk for spina bifida. American Journal of Medical Genetics Part A 149A:2, 155-160
CrossRef117
Angela E. Lin, Sonja A. Rasmussen, Angela Scheuerle, Roger E. Stevenson. (2009) Clinical geneticists in birth defects surveillance and epidemiology research programs: Past, present and future roles. Birth Defects Research Part A: Clinical and Molecular Teratology 85:1, 69-75
CrossRef118
Hisanori MINAKAMI. (2009) Increased Folate Intake is Recommended. Japanese Journal of Complementary and Alternative Medicine 6:2, 53-57
CrossRef119
Suzan L. Carmichael, Wei Yang, Adolfo Correa, Richard S. Olney, Gary M. Shaw. (2009) Hypospadias and Intake of Nutrients Related to One-Carbon Metabolism. The Journal of Urology 181:1, 315-321
CrossRef120
Ikuyo Okai, Atsuo Kondo, Chiyogiku Mitsuguchi. (2009) Folic Acid and Neural Tube Defects: Assessment of the Awareness of Folic Acid and Life-style Intervention of Dietitians (2007). The Japanese Journal of Nutrition and Dietetics 67:5, 279-283
CrossRef121
Suzan L. Carmichael, John S. Witte, Gary M. Shaw. (2009) Nutrient Pathways and Neural Tube Defects. Epidemiology 20:1, 67-73
CrossRef122
Helmut B. Heseker, Joel B. Mason, Jacob Selhub, Irwin H. Rosenberg, Paul F. Jacques. (2009) Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. British Journal Of Nutrition 102:2, 173
CrossRef123
Atsuo Kondo, Osamu Kamihira, Hideo Ozawa. (2009) Neural tube defects: Prevalence, etiology and prevention. International Journal of Urology 16:1, 49-57
CrossRef124
Karen N. Bell, Godfrey P. Oakley. (2009) Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Research Part A: Clinical and Molecular Teratology 85:1, 102-107
CrossRef125
Sonja A. Rasmussen, J. David Erickson, Susan E. Reef, Danielle S. Ross. (2009) Teratology: From science to birth defects prevention. Birth Defects Research Part A: Clinical and Molecular Teratology 85:1, 82-92
CrossRef126
B. S. Mosley, M. A. Cleves, A. M. Siega-Riz, G. M. Shaw, M. A. Canfield, D. K. Waller, M. M. Werler, C. A. Hobbs, . (2008) Neural Tube Defects and Maternal Folate Intake Among Pregnancies Conceived After Folic Acid Fortification in the United States. American Journal of Epidemiology 169:1, 9-17
CrossRef127
B. S. Mosley, C. A. Hobbs. (2008) Mosley and Hobbs Respond to "Folic Acid Fortification and Neural Tube Defects". American Journal of Epidemiology 169:1, 22-23
CrossRef128
Marie Sutton, Leslie E. Daly, Peadar N. Kirke. (2008) Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Research Part A: Clinical and Molecular Teratology 82:10, 701-709
CrossRef129
Robert M. Cabrera, Gary M. Shaw, Johnathan L. Ballard, Suzan L. Carmichael, Wei Yang, Edward J. Lammer, Richard H. Finnell. (2008) Autoantibodies to folate receptor during pregnancy and neural tube defect risk. Journal of Reproductive Immunology 79:1, 85-92
CrossRef130
Masayo Matsuzaki, Megumi Haruna, Erika Ota, Satoshi Sasaki, Yasushi Nagai, Sachiyo Murashima. (2008) Dietary folate intake, use of folate supplements, lifestyle factors, and serum folate levels among pregnant women in Tokyo, Japan. Journal of Obstetrics and Gynaecology Research
CrossRef131
N. Ceren Alemdaroglu, Ulrich Dietz, Siegfried Wolffram, Hildegard Spahn-Langguth, Peter Langguth. (2008) Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharmaceutics & Drug Disposition 29:6, 335-348
CrossRef132
G. Paolo Strozzi, Luca Mogna. (2008) Quantification of Folic Acid in Human Feces After Administration of Bifidobacterium Probiotic Strains. Journal of Clinical Gastroenterology 42, S179-S184
CrossRef133
Gong Chen, Xinming Song, Ying Ji, Lei Zhang, Lijun Pei, Jiapeng Chen, Jufen Liu, Chengfu Li, Xiaoying Zheng. (2008) Prevention of NTDs with periconceptional multivitamin supplementation containing folic acid in China. Birth Defects Research Part A: Clinical and Molecular Teratology 82:8, 592-596
CrossRef134
FJE Vajda. (2008) Treatment options for pregnant women with epilepsy. Expert Opinion on Pharmacotherapy 9:11, 1859-1868
CrossRef135
B BAROZ, G KOREN, P NGUYEN, B KAPUR. (2008) Folate fortification and supplementation—Are we there yet?. Reproductive Toxicology 25:4, 408-412
CrossRef136
Hong-Yang Zhang, Guo-An Luo, Qiong-Lin Liang, Yong Wang, Hui-Hua Yang, Yi-Ming Wang, Xiao-Ying Zheng, Xin-Ming Song, Gong Chen, Ting Zhang, Jian-Xin Wu. (2008) Neural tube defects and disturbed maternal folate- and homocysteine-mediated one-carbon metabolism. Experimental Neurology 212:2, 515-521
CrossRef137
J Rosenthal, G Milla, A Flores, M Yon, C Pfeiffer, E Umaña, N Skerrette, F Barahona, . (2008) Effect of different dosage and administration schedules of folic acid on blood folate levels in a population of Honduran women of reproductive age. Public Health Nutrition 11:08,
CrossRef138
Sheree L. Boulet, Quanhe Yang, Cara Mai, Russell S. Kirby, Julianne S. Collins, James M. Robbins, Robert Meyer, Mark A. Canfield, Joe Mulinare, . (2008) Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Research Part A: Clinical and Molecular Teratology 82:7, 527-532
CrossRef139
Sonja A. Rasmussen, Susan Y. Chu, Shin Y. Kim, Christopher H. Schmid, Joseph Lau. (2008) Maternal obesity and risk of neural tube defects: a metaanalysis. American Journal of Obstetrics and Gynecology 198:6, 611-619
CrossRef140
J. Rück, J. Bauer. (2008) Schwangerschaftsberatung und Epilepsie. Der Nervenarzt 79:6, 691-695
CrossRef141
Mirande Candito, Romain Rivet, Bernard Herbeth, Catherine Boisson, René-Charles Rudigoz, Dominique Luton, Hubert Journel, Jean-François Oury, François Roux, Robert Saura, Isabelle Vernhet, Pascal Gaucherand, Françoise Muller, Béatrice Guidicelli, Hélène Heckenroth, Patrice Poulain, Martine Blayau, Christine Francannet, Laurence Roszyk, Cécile Brustié, Pascal Staccini, Philippe Gérard, Nathalie Fillion-Emery, Rosa-Maria Guéant-Rodriguez, Emmanuel Van Obberghen, Jean-Louis Guéant. (2008) Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: A multicenter case–control study. American Journal of Medical Genetics Part A 146A:9, 1128-1133
CrossRef142
Jun Zhang, Yinghui Liu, Susan Meikle, Junchi Zheng, Wenyu Sun, Zhu Li. (2008) Cesarean Delivery on Maternal Request in Southeast China. Obstetrics & Gynecology 111:5, 1077-1082
CrossRef143
Abdul-Rauf Sayed, David Bourne, Robert Pattinson, Jo Nixon, Bertram Henderson. (2008) Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Research Part A: Clinical and Molecular Teratology 82:4, 211-216
CrossRef144
Y. Liu, J. Liu, R. Ye, A. Ren, S. Li, Z. Li. (2008) Association of Education and the Occurrence of Low Birthweight in Rural Southern China During the Early and Late 1990s. American Journal of Public Health 98:4, 687-691
CrossRef145
Sofia Hjortmo, Johan Patring, Thomas Andlid. (2008) Growth rate and medium composition strongly affect folate content in Saccharomyces cerevisiae. International Journal of Food Microbiology 123:1-2, 93-100
CrossRef146
George L. Wehby, Jeffrey C. Murray. (2008) The Effects of Prenatal Use of Folic Acid and Other Dietary Supplements on Early Child Development. Maternal and Child Health Journal 12:2, 180-187
CrossRef147
Y WANG, H ZHANG, Q LIANG, H YANG, Y WANG, Q LIU, P HU, X ZHENG, X SONG, G CHEN. (2008) Simultaneous quantification of 11 pivotal metabolites in neural tube defects by HPLC–electrospray tandem mass spectrometry. Journal of Chromatography B 863:1, 94-100
CrossRef148
Roman Pawlak, Denise Brown, Mary Kay Meyer, Carol Connell, Kathleen Yadrick, J. T. Johnson, Ann Blackwell. (2008) Theory of Planned Behavior and Multivitamin Supplement Use in Caucasian College Females. The Journal of Primary Prevention 29:1, 57-71
CrossRef149
Hee-Ah KIM, Hyeon-Sook LIM. (2008) Dietary Folate Intake, Blood Folate Status, and Urinary Folate Catabolite Excretion in Korean Women of Childbearing Age. Journal of Nutritional Science and Vitaminology 54:4, 291-297
CrossRef150
Roman Pawlak, Denise Brown, Mary Kay Meyer, Carol Connell, Kathleen Yadrick, J. T. Johnson, Ann Blackwell. (2008) Theory of Planned Behavior and Multivitamin Supplement Use in Caucasian College Females. The Journal of Primary Prevention 29:1, 57
CrossRef151
John A. A. Nichols, Edward Paul P. Curtis, Margaret P. Rayman. (2008) Survey of total folate intake at conception and assessment of impact of fortification. Journal of Nutritional and Environmental Medicine 17:1, 44-55
CrossRef152
D Kjaer, E Horvath-Puhó, J Christensen, M Vestergaard, AE Czeizel, HT Sørensen, J Olsen. (2008) Antiepileptic drug use, folic acid supplementation, and congenital abnormalities: a population-based case-control study. BJOG: An International Journal of Obstetrics & Gynaecology 115:1, 98-103
CrossRef153
RICHARD B. JOHNSTON. (2008) Will Increasing Folic Acid in Fortified Grain Products Further Reduce Neural Tube Defects without Causing Harm?: Consideration of the Evidence. Pediatric Research 63:1, 2-8
CrossRef154
Shveta Taparia, Janée Gelineau-van Waes, Thomas H. Rosenquist, Richard H. Finnell. (2007) Importance of folate-homocysteine homeostasis during early embryonic development. Clinical Chemistry and Laboratory Medicine 45:12, 1717-1727
CrossRef155
Young-In Kim. (2007) Folic Acid Fortification and Supplementation-Good for Some but Not So Good for Others. Nutrition Reviews 65:11, 504-511
CrossRef156
Scott D. Grosse, Julianne S. Collins. (2007) Folic acid supplementation and neural tube defect recurrence prevention. Birth Defects Research Part A: Clinical and Molecular Teratology 79:11, 737-742
CrossRef157
Noel W. Solomons. (2007) Food Fortification with Folic Acid: Has the Other Shoe Dropped?. Nutrition Reviews 65:11, 512-515
CrossRef158
Rebecca H. Bitsko, Jennita Reefhuis, Paul A. Romitti, Cynthia A. Moore, Margaret A. Honein. (2007) Periconceptional consumption of vitamins containing folic acid and risk for multiple congenital anomalies. American Journal of Medical Genetics Part A 143A:20, 2397-2405
CrossRef159
Xue Gu, Liangming Lin, Xiaoying Zheng, Ting Zhang, Xinming Song, Jinfeng Wang, Xinhu Li, Peizhen Li, Gong Chen, Jilei Wu, Lihua Wu, Jufen Liu. (2007) High prevalence of NTDs in Shanxi Province: A combined epidemiological approach. Birth Defects Research Part A: Clinical and Molecular Teratology 79:10, 702-707
CrossRef160
Natalie S. The, Margaret A. Honein, Alissa R. Caton, Cynthia A. Moore, Anna Maria Siega-Riz, Charlotte M. Druschel, . (2007) Risk factors for isolated biliary atresia, National Birth Defects Prevention Study, 1997–2002. American Journal of Medical Genetics Part A 143A:19, 2274-2284
CrossRef161
De Wals, Philippe, Tairou, Fassiatou, Van Allen, Margot I., Uh, Soo-Hong, Lowry, R. Brian, Sibbald, Barbara, Evans, Jane A., Van den Hof, Michiel C., Zimmer, Pamela, Crowley, Marian, Fernandez, Bridget, Lee, Nora S., Niyonsenga, Theophile, . (2007) Reduction in Neural-Tube Defects after Folic Acid Fortification in Canada. New England Journal of Medicine 357:2, 135-142
Full Text162
F.J.E. Vajda, C.M. Lander, A. Hitchcock, J. Graham, C. Solinas, T. O’Brien, M.J. Eadie. (2007) Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences. Journal of Clinical Neuroscience 14:7, 611-617
CrossRef163
Katika Nawapun, Vorapong Phupong. (2007) Awareness of the benefits of folic acid and prevalence of the use of folic acid supplements to prevent neural tube defects among Thai women. Archives of Gynecology and Obstetrics 276:1, 53-57
CrossRef164
Michelle M Murphy. (2007) Homocysteine: biomarker or cause of adverse pregnancy outcome?. Biomarkers in Medicine 1:1, 145-157
CrossRef165
María Luisa Martínez-Frías. (2007) Adecuación de las dosis de ácido fólico en la prevención de defectos congénitos. Medicina Clínica 128:16, 609-616
CrossRef166
Zhiwen Li, Aiguo Ren, Jianmeng Liu, Lijun Pei, Le Zhang, Zhanying Guo, Zhu Li. (2007) Maternal flu or fever, medication use, and neural tube defects: A population-based case-control study in Northern China. Birth Defects Research Part A: Clinical and Molecular Teratology 79:4, 295-300
CrossRef167
Huiping Zhu, Bogdan J. Wlodarczyk, Melissa Scott, Wei Yu, Michelle Merriweather, Janee Gelineau-van Waes, Robert J. Schwartz, Richard H. Finnell. (2007) Cardiovascular abnormalities inFolr1 knockout mice and folate rescue. Birth Defects Research Part A: Clinical and Molecular Teratology 79:4, 257-268
CrossRef168
Joachim Schüz, Thomas Weihkopf, Peter Kaatsch. (2007) Medication use during pregnancy and the risk of childhood cancer in the offspring. European Journal of Pediatrics 166:5, 433-441
CrossRef169
Young-In Kim. (2007) Folate and colorectal cancer: An evidence-based critical review. Molecular Nutrition & Food Research 51:3, 267-292
CrossRef170
Atsuo Kondo, Osamu Kamihira, Momokazu Gotoh, Hideo Ozawa, Tchun Yong Lee, Alex T-L. Lin, Seung-Ryong Kim, Ho-Hsiung Lin. (2007) Folic acid prevents neural tube defects: International comparison of awareness among obstetricians/gynecologists and urologists. Journal of Obstetrics and Gynaecology Research 33:1, 63-67
CrossRef171
Cécile Chevrier, Claire Perret, Michel Bahuau, Huiping Zhu, Agnès Nelva, Christine Herman, Christine Francannet, Elisabeth Robert-Gnansia, Richard H. Finnell, Sylvaine Cordier. (2007) Fetal and maternalMTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. American Journal of Medical Genetics Part A 143A:3, 248-257
CrossRef172
Wei Lu, Huiping Zhu, Shu Wen, Cecile Laurent, Gary M. Shaw, Edward J. Lammer, Richard H. Finnell. (2007) Screening for novelPAX3 polymorphisms and risks of spina bifida. Birth Defects Research Part A: Clinical and Molecular Teratology 79:1, 45-49
CrossRef173
Lisa Houghton, Deborah O'Connor. 2007. .
CrossRef174
N Mito, H Takimoto, K Umegaki, A Ishiwaki, K Kusama, H Fukuoka, S Ohta, S Abe, M Yamawaki, H Ishida, N Yoshiike. (2007) Folate intakes and folate biomarker profiles of pregnant Japanese women in the first trimester. European Journal of Clinical Nutrition 61:1, 83-90
CrossRef175
Aiguo Ren, Juan Wang. (2006) Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: A meta-analysis. Fertility and Sterility 86:6, 1716-1722
CrossRef176
Isla DOBSON, Celia DEVENISH, C. Murray SKEAFF, Tim J. GREEN. (2006) Periconceptional folic acid use among women giving birth at Queen Mary Maternity Hospital in Dunedin. The Australian and New Zealand Journal of Obstetrics and Gynaecology 46:6, 534-537
CrossRef177
A. Michaelidou, J. Steijns. (2006) Nutritional and technological aspects of minor bioactive components in milk and whey: Growth factors, vitamins and nucleotides. International Dairy Journal 16:11, 1421-1426
CrossRef178
Lorenzo D. Botto, Alessandra Lisi, Carol Bower, Mark A. Canfield, Nirupa Dattani, Catherine De Vigan, Hermien De Walle, David J. Erickson, Jane Halliday, Lorentz M. Irgens, R. Brian Lowry, Robert McDonnell, Julia Metneki, Simone Poetzsch, Annukka Ritvanen, Elisabeth Robert-Gnansia, Csaba Siffel, Claude Stoll, Pierpaolo Mastroiacovo. (2006) Trends of selected malformations in relation to folic acid recommendations and fortification: An international assessment. Birth Defects Research Part A: Clinical and Molecular Teratology 76:10, 693-705
CrossRef179
A REN, L ZHANG, Z LI, L HAO, Y TIAN, Z LI. (2006) Awareness and use of folic acid, and blood folate concentrations among pregnant women in northern China—An area with a high prevalence of neural tube defects. Reproductive Toxicology 22:3, 431-436
CrossRef180
Gregory D. Bennett, Kristine Moser, Tammy Chaudoin, Thomas H. Rosenquist. (2006) The expression of the NR1-subunit of the NMDA receptor during mouse and early chicken development. Reproductive Toxicology 22:3, 536-541
CrossRef181
James C Huhta, Kersti Linask, Lynn Bailey. (2006) Recent advances in the prevention of congenital heart disease. Current Opinion in Pediatrics 18:5, 484-489
CrossRef182
Andrew J. Copp. 2006. Neural Tube Defects, Molecular Biology of. .
CrossRef183
Daniel Doherty, David B. Shurtleff. (2006) Pediatric perspective on prenatal counseling for myelomeningocele. Birth Defects Research Part A: Clinical and Molecular Teratology 76:9, 645-653
CrossRef184
Robert R. Miller, Casey M. Hay, Theodore R. Striegnitz, Laura E. Honsey, Carrie E. Coykendall, Kevin D. Blacquiere. (2006) Exogenous glycine partially attenuates homocysteine-induced apoptosis and membrane peroxidation in chick embryos. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 144:1, 25-33
CrossRef185
Henk J. Blom, Gary M. Shaw, Martin den Heijer, Richard H. Finnell. (2006) Neural tube defects and folate: case far from closed. Nature Reviews Neuroscience 7:9, 724-731
CrossRef186
Tina B Mikkelsen, Merete Osler, Sjurdur F Olsen. (2006) Validity of protein, retinol, folic acid and n–3 fatty acid intakes estimated from the food-frequency questionnaire used in the Danish National Birth Cohort. Public Health Nutrition 9:06,
CrossRef187
Johan D. M. Patring, Sofia B. Hjortmo, Jelena A. Jastrebova, Ulla K. Svensson, Thomas A. Andlid, I. Margaretha Jägerstad. (2006) Characterization and quantification of folates produced by yeast strains isolated from kefir granules. European Food Research and Technology 223:5, 633-637
CrossRef188
Laura E. Martínez de Villarreal, Patricia Arredondo, Ricardo Hernández, Jesús Z. Villarreal. (2006) Weekly Administration of Folic Acid and Epidemiology of Neural Tube Defects. Maternal and Child Health Journal 10:5, 397-401
CrossRef189
Carol Bower, Nicholas Klerk, Siobhan Hickling, Gina Ambrosini, Leon Flicker, Elizabeth Geelhoed, Elizabeth Milne. (2006) Assessment of the potential effect of incremental increases in folic acid intake on neural tube defects in Australia and New Zealand. Australian and New Zealand Journal of Public Health 30:4, 369-374
CrossRef190
V. Michael Whitehead. (2006) Acquired and inherited disorders of cobalamin and folate in children. British Journal of Haematology 134:2, 125-136
CrossRef191
Mattias Gäreskog, Ulf J. Eriksson, Parri Wentzel. (2006) Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Research Part A: Clinical and Molecular Teratology 76:6, 483-490
CrossRef192
Le Zhang, Aiguo Ren, Zhiwen Li, Ling Hao, Yihua Tian, Zhu Li. (2006) Folate concentrations and folic acid supplementation among women in their first trimester of pregnancy in a rural area with a high prevalence of neural tube defects in Shanxi, China. Birth Defects Research Part A: Clinical and Molecular Teratology 76:6, 461-466
CrossRef193
Margot I. Allen, Erin Boyle, Paul Thiessen, Deborah McFadden, Douglas Cochrane, G. Keith Chambers, Sylvie Langlois, Patricia Stathers, Beverly Irwin, Elizabeth Cairns, Patrick MacLeod, Marie -France Delisle, Soo -Hong Uh. (2006) The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia. Journal of Applied Genetics 47:2, 151-158
CrossRef194
Johan D. M. Patring, Svetlana A. Lanina, Jelena A. Jastrebova. (2006) Applicability of alkyl-bonded ultra-pure silica stationary phases for gradient reversed-phase HPLC of folates with conventional and volatile buffers under highly aqueous conditions. Journal of Separation Science 29:6, 889-904
CrossRef195
Gregory D. Bennett, Janee VanWaes, Kristine Moser, Tammy Chaudoin, Lois Starr, Thomas H. Rosenquist. (2006) Failure of homocysteine to induce neural tube defects in a mouse model. Birth Defects Research Part B: Developmental and Reproductive Toxicology 77:2, 89-94
CrossRef196
Zhiwen Li, Aiguo Ren, Le Zhang, Rongwei Ye, Song Li, Junchi Zheng, Shixin Hong, Taimei Wang, Zhu Li. (2006) Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Research Part A: Clinical and Molecular Teratology 76:4, 237-240
CrossRef197
Tharanga Thoradeniya, Rajitha Wickremasinghe, Ramani Ramanayake, Sunethra Atukorala. (2006) Low folic acid status and its association with anaemia in urban adolescent girls and women of childbearing age in Sri Lanka. British Journal of Nutrition 95:03, 511
CrossRef198
H. Madziva, K. Kailasapathy, M. Phillips. (2006) Evaluation of alginate–pectin capsules in Cheddar cheese as a food carrier for the delivery of folic acid. LWT - Food Science and Technology 39:2, 146-151
CrossRef199
Nils Milman, Keld-Erik Byg, Anne-Mette Hvas, Thomas Bergholt, Lisbeth Eriksen. (2006) Erythrocyte folate, plasma folate and plasma homocysteine during normal pregnancy and postpartum: a longitudinal study comprising 404 Danish women. European Journal of Haematology 76:3, 200-205
CrossRef200
Zhiwen Li, Aiguo Ren, Le Zhang, Zhanying Guo, Zhu Li. (2006) A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatric and Perinatal Epidemiology 20:1, 43-53
CrossRef201
Huiping Zhu, Wei Yang, Wei Lu, Jing Zhang, Gary M. Shaw, Edward J. Lammer, Richard H. Finnell. (2006) A known functional polymorphism (Ile120Val) of the human PCMT1 gene and risk of spina bifida. Molecular Genetics and Metabolism 87:1, 66-70
CrossRef202
P M Finglas, K de Meer, A Molloy, P Verhoef, K Pietrzik, H J Powers, D van der Straeten, M Jägerstad, G Varela-Moreiras, T van Vliet. (2006) Research goals for folate and related B vitamin in Europe. European Journal of Clinical Nutrition 60:2, 287
CrossRef203
Radim J. Sram, Blanka Binkova, Zdena Lnenickova, Ivo Solansky, Jan Dejmek. (2005) The impact of plasma folate levels of mothers and newborns on intrauterine growth retardation and birth weight. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 591:1-2, 302-310
CrossRef204
Anne Klusmann, Beate Heinrich, Heike Stöpler, Jutta Gärtner, Ertan Mayatepek, Rüdiger Von Kries. (2005) A decreasing rate of neural tube defects following the recommendations for periconceptional folic acid supplementation. Acta Paediatrica 94:11, 1538-1542
CrossRef205
S. D. Grosse, N. J. Waitzman, P. S. Romano, J. Mulinare. (2005) Reevaluating the Benefits of Folic Acid Fortification in the United States: Economic Analysis, Regulation, and Public Health. American Journal of Public Health 95:11, 1917-1922
CrossRef206
Richard H Carmona. (2005) The global challenges of birth defects and disabilities. The Lancet 366:9492, 1142-1144
CrossRef207
Vinita S Salvi, Kaizad R Damania. (2005) Neural tube defects in India—time for action. The Lancet 366:9489, 871-872
CrossRef208
Mark Lawrence. (2005) Assessing the case for mandatory folate fortification: policy-making in the face of scientific uncertainties. Australian and New Zealand Journal of Public Health 29:4, 328-330
CrossRef209
Nataliya Yuskiv, Margaret A. Honein, Cynthia A. Moore. (2005) Reported multivitamin consumption and the occurrence of multiple congenital anomalies. American Journal of Medical Genetics Part A 136A:1, 1-7
CrossRef210
Huiping Zhu, Stacey Curry, Shu Wen, Ned J. Wicker, Gary M. Shaw, Edward J. Lammer, Wei Yang, Toghrul Jafarov, Richard H. Finnell. (2005) Are the betaine-homocysteine methyltransferase (BHMT andBHMT2) genes risk factors for spina bifida and orofacial clefts?. American Journal of Medical Genetics Part A 135A:3, 274-277
CrossRef211
Anne M. Molloy. (2005) The role of folic acid in the prevention of neural tube defects. Trends in Food Science & Technology 16:6-7, 241-245
CrossRef212
Julianne Byrne, Susan Carolan, Rashad Arcement, Matthew Kozlowski, Inna Taller, Stephanie Ried, Robert Keating. (2005) An intervention study to increase knowledge and use of folic acid among relatives in neural tube defect-affected families in Washington, D.C.. Birth Defects Research Part A: Clinical and Molecular Teratology 73:6, 424-429
CrossRef213
Jesse F. Gregory, Eoin P. Quinlivan, Steven R. Davis. (2005) Integrating the issues of folate bioavailability, intake and metabolism in the era of fortification. Trends in Food Science & Technology 16:6-7, 229-240
CrossRef214
Lijun Pei, Huiping Zhu, Aiguo Ren, Zhiwen Li, Ling Hao, Richard H. Finnell, Zhu Li. (2005) Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population. Birth Defects Research Part A: Clinical and Molecular Teratology 73:6, 430-433
CrossRef215
T.W. Sadler. (2005) Embryology of neural tube development. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 135C:1, 2-8
CrossRef216
John M. Tilford, Scott D. Grosse, James M. Robbins, Jeffrey M. Pyne, Mario A. Cleves, Charlotte A. Hobbs. (2005) Health state preference scores of children with spina bifida and their caregivers. Quality of Life Research 14:4, 1087-1098
CrossRef217
(2005) VOLUME 6, NUMBER 4. Journal of Agromedicine 9:2, 375-394
CrossRef218
Atsuo Kondo, Osamu Kamihira, Yoichi Shimosuka, Ikuyo Okai, Momokazu Gotoh, Hideo Ozawa. (2005) Awareness of the role of folic acid, dietary folate intake and plasma folate concentration in Japan. Journal of Obstetrics and Gynaecology Research 31:2, 172-177
CrossRef219
L.J. Tata, T.R. Card, R.F.A. Logan, R.B. Hubbard, C.J.P. Smith, J. West. (2005) Fertility and pregnancy-related events in women with celiac disease: A population-based cohort study. Gastroenterology 128:4, 849-855
CrossRef220
Erminiana D. MendonçA, Cristiane M. Gutierrez, Luiz C. Peres. (2005) Brain tissue fragments in the amniotic fluid of rats with neural tube defect. Pathology 37:2, 152-156
CrossRef221
Helga V. Toriello. (2005) Folic acid and neural tube defects. Genetics in Medicine 7:4, 283-284
CrossRef222
Stein Emil Vollset, H??kon K. Gjessing, Anne Tandberg, Thorbj??rn R??nning, Lorentz M. Irgens, Valborg Baste, Roy M. Nilsen, Anne Kjersti Daltveit. (2005) Folate Supplementation and Twin Pregnancies. Epidemiology 16:2, 201-205
CrossRef223
Ofer Spiegelstein, Amy Gould, Bogdan Wlodarczyk, Marlene Tsie, Xiufen Lu, Chris Le, Aron Troen, Jacob Selhub, Jorge A. Piedrahita, J. Michael Salbaum, Claudia Kappen, Stepan Melnyk, Jill James, Richard H. Finnell. (2005) Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies. Toxicology and Applied Pharmacology 203:1, 18-26
CrossRef224
K. Zwiauer. (2005) Prophylaxe von Neuralrohrdefekten mit Fols
ure. Der Gyn
CrossRef225
P.N. Kirke, J.M. Scott. 2005. PREGNANCY | Prevention of Neural Tube Defects. , 15-27.
CrossRef226
Lolkje T.W. de Jong-van den Berg, Sonia Hernandez-Diaz, Martha M. Werler, Carol Louik, Allen A. Mitchell. (2005) Trends and predictors of folic acid awareness and periconceptional use in pregnant women. American Journal of Obstetrics and Gynecology 192:1, 121-128
CrossRef227
L.H. Allen. 2005. PREGNANCY | Nutrient Requirements. , 521-528.
CrossRef228
S. Ruggeri. (2004) Folate from food: four is enough . . . choosing right. Nutrition Bulletin 29:4, 356-358
CrossRef229
M. G. Venkatesh Mannar, R. Sankar. (2004) Micronutrient fortification of foods — rationale, application and impact. The Indian Journal of Pediatrics 71:11, 997-1002
CrossRef230
Godfrey P. Oakley, Karen N. Bell, Mary Beth Weber. (2004) Recommendations for accelerating global action to prevent folic acid-preventable birth defects and other folate-deficiency diseases: Meeting of experts on preventing folic acid-preventable neural tube defects. Birth Defects Research Part A: Clinical and Molecular Teratology 70:11, 835-837
CrossRef231
Andrew E. Czeizel, M
CrossRef232
Liselotte E. Jensen, Sandrine Barbaux, Katy Hoess, Sven Fraterman, Alexander S. Whitehead, Laura E. Mitchell. (2004) The human T locus and spina bifida risk. Human Genetics 115:6, 475-482
CrossRef233
Laura E Mitchell, N Scott Adzick, Jeanne Melchionne, Patrick S Pasquariello, Leslie N Sutton, Alexander S Whitehead. (2004) Spina bifida. The Lancet 364:9448, 1885-1895
CrossRef234
Godfrey P. Oakley, Mary Beth Weber, Karen N. Bell, Paul Colditz. (2004) Scientific evidence supporting folic acid fortification of flour in Australia and New Zealand. Birth Defects Research Part A: Clinical and Molecular Teratology 70:11, 838-841
CrossRef235
Vibeke K Knudsen, Ivanka Orozova-Bekkevold, Lone B Rasmussen, Tina B Mikkelsen, Kim F Michaelsen, Sjúrður F Olsen. (2004) Low compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification?. Public Health Nutrition 7:07,
CrossRef236
Caroline J. Simmons, Bridget S. Mosley, Cynthia A. Fulton-Bond, Charlotte A. Hobbs. (2004) Birth defects in Arkansas: Is folic acid fortification making a difference?. Birth Defects Research Part A: Clinical and Molecular Teratology 70:9, 559-564
CrossRef237
Hamisu M. Salihu, Zakari Y. Aliyu, Bosny J. Pierre-Louis, Francis A. Obuseh, Charlotte M. Druschel, Russell S. Kirby. (2004) Omphalocele and gastroschisis: Black-white disparity in infant survival. Birth Defects Research Part A: Clinical and Molecular Teratology 70:9, 586-591
CrossRef238
Ofer Spiegelstein, Laura E. Mitchell, Michelle Y. Merriweather, Ned J. Wicker, Qiang Zhang, Edward J. Lammer, Richard H. Finnell. (2004) Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Developmental Dynamics 231:1, 221-231
CrossRef239
Bermans J. Iskandar, Aaron Nelson, Daniel Resnick, J. H. Pate Skene, Peng Gao, Chenara Johnson, Thomas D. Cook, Nithya Hariharan. (2004) Folic acid supplementation enhances repair of the adult central nervous system. Annals of Neurology 56:2, 221-227
CrossRef240
R FINNELL. (2004) Gene–nutrient interactions: importance of folates and retinoids during early embryogenesis. Toxicology and Applied Pharmacology 198:2, 75-85
CrossRef241
T
CrossRef242
Pascal M.W Groenen, Iris A.L.M van Rooij, Petronella G.M Peer, Rob H Gooskens, Gerhard A Zielhuis, Régine P.M Steegers-Theunissen. (2004) Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. American Journal of Obstetrics and Gynecology 191:1, 11-17
CrossRef243
Michael Rychlik. (2004) Revised folate content of foods determined by stable isotope dilution assays. Journal of Food Composition and Analysis 17:3-4, 475-483
CrossRef244
Nataliya Yuskiv, Clark O. Andelin, Svitlana Polischuk, Oleksandr Shevchuk, Zoryana Sosynyuk, Tetyana Vihovska, Lyubov Yevtushok, Godfrey P. Oakley, Wladimir Wertelecki. (2004) High rates of neural tube defects in Ukraine. Birth Defects Research Part A: Clinical and Molecular Teratology 70:6, 400-402
CrossRef245
Liselotte E. Jensen, Amelia M. Wall, Michelle Cook, Katy Hoess, Caroline F. Thorn, Alexander S. Whitehead, Laura E. Mitchell. (2004) A commonABCC2 promoter polymorphism is not a determinant of the risk of spina bifida. Birth Defects Research Part A: Clinical and Molecular Teratology 70:6, 396-399
CrossRef246
Godfrey P. Oakley. (2004) Oral Synthetic Folic Acid and Vitamin B 12 Supplements Work-If One Consumes Them. Nutrition Reviews 62, S22-S26
CrossRef247
S. Jill James. (2004) Maternal metabolic phenotype and risk of down syndrome: Beyond genetics. American Journal of Medical Genetics 127A:1, 1-4
CrossRef248
(2004) NTP-CERHR Expert Panel report on the reproductive and developmental toxicity of methanol. Reproductive Toxicology 18:3, 303-390
CrossRef249
Joel G. Ray, Gita Singh, Robert F. Burrows. (2004) Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG: An International Journal of Obstetrics and Gynaecology 111:5, 399-408
CrossRef250
S CZERNICHOW, J BLACHER, D ARVEILER, P DUCIMETIERE. (2004) Prévention nutritionnelle par les vitamines B : vers un programme-pilote d’enrichissement des farines en France ?. Cahiers de Nutrition et de Diététique 39:2, 121-126
CrossRef251
Karen S. Brown, Michelle Cook, Katy Hoess, Alexander S. Whitehead, Laura E. Mitchell. (2004) Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Research Part A: Clinical and Molecular Teratology 70:3, 101-106
CrossRef252
Mark I. Evans, Elisa Llurba, Ellen J. Landsberger, Joseph E. O’Brien, Harold H. Harrison. (2004) Impact of Folic Acid Fortification in the United States: Markedly Diminished High Maternal Serum Alpha-Fetoprotein Values. Obstetrics & Gynecology 103:3, 474-479
CrossRef253
Lorenzo D. Botto, Richard S. Olney, J. David Erickson. (2004) Vitamin supplements and the risk for congenital anomalies other than neural tube defects. American Journal of Medical Genetics 125C:1, 12-21
CrossRef254
Huiping Zhu, Ned J Wicker, Kelly Volcik, Jing Zhang, Gary M Shaw, Edward J Lammer, Lucina Suarez, Mark Canfield, Richard H Finnell. (2004) Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Molecular Genetics and Metabolism 81:2, 127-132
CrossRef255
Young-In Kim. (2004) Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies. Environmental and Molecular Mutagenesis 44:1, 10-25
CrossRef256
Eduardo E. Castilla, I
CrossRef257
Ofer Spiegelstein, Michelle Y. Merriweather, Ned J. Wicker, Richard H. Finnell. (2003) Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice. Birth Defects Research Part A: Clinical and Molecular Teratology 67:12, 974-978
CrossRef258
Quanhe Yang, Michael Atkinson, J. David Erickson. (2003) Method of weighted proportion of reproductive-aged women taking folic acid supplements to predict a neural tube defect rate decline. Birth Defects Research Part A: Clinical and Molecular Teratology 67:12, 959-967
CrossRef259
Barbara Franke, Riko Klootwijk, Bianca Lemmers, Carolien G.F. De Kovel, Regine P.M. Steegers-Theunissen, Edwin C.M. Mariman. (2003) Phenotype of the neural tube defect mouse model bent tail is not sensitive to maternal folinic acid,myo-inositol, or zinc supplementation. Birth Defects Research Part A: Clinical and Molecular Teratology 67:12, 979-984
CrossRef260
Philippe De Wals, Ira David Rusen, Nora S. Lee, Pascale Morin, Th
CrossRef261
Godfrey P. Oakley. (2003) Folate deficiency is an ?imminent health hazard? causing a worldwide birth defects epidemic. Birth Defects Research Part A: Clinical and Molecular Teratology 67:11, 903-904
CrossRef262
Maria da Costa, Jeffrey M. Sequeira, Sheldon P. Rothenberg, Jeremy Weedon. (2003) Antibodies to folate receptors impair embryogenesis and fetal development in the rat. Birth Defects Research Part A: Clinical and Molecular Teratology 67:10, 837-847
CrossRef263
Adolfo Correa-Villase
CrossRef264
Lorenzo D. Botto, Joseph Mulinare, J. David Erickson. (2003) Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. American Journal of Medical Genetics 121A:2, 95-101
CrossRef265
Yolanda Cartwright, Mary Story. 2003. Nutritional Guidelines During Pregnancy and Lactation. , 75-98.
CrossRef266
Shirley J Thompson, Myriam E Torres, Roger E Stevenson, Jane H Dean, Robert G Best. (2003) Periconceptional Multivitamin Folic Acid Use, Dietary Folate, Total Folate and Risk of Neural Tube Defects in South Carolina. Annals of Epidemiology 13:6, 412-418
CrossRef267
Kristin Braekke, Anne Cathrine Staff. (2003) Periconceptional use of folic acid supplements in Oslo. Acta Obstetricia et Gynecologica Scandinavica 82:7, 620-627
CrossRef268
Song Li, Cynthia A. Moore, Zhu Li, R. J. Berry, Jacqueline Gindler, Shi-xin Hong, Yecai Liu, Joseph Mulinare, Lee-Yang Wong, Hai-qin Gu, J. David Erickson. (2003) A population-based birth defects surveillance system in the People's Republic of China. Paediatric and Perinatal Epidemiology 17:3, 287-293
CrossRef269
2003. Introduction. .
CrossRef270
Lauren Frey, W. Allen Hauser. (2003) Epidemiology of Neural Tube Defects. Epilepsia 44, 4-13
CrossRef271
Karin M. van der Pal-de Bruin, Peter G.M. van der Heijden, Simone E. Buitendijk, A.Lya den Ouden. (2003) Periconceptional folic acid use and the prevalence of neural tube defects in The Netherlands. European Journal of Obstetrics & Gynecology and Reproductive Biology 108:1, 33-39
CrossRef272
Gad Barkai, Svetlana Arbuzova, Michal Berkenstadt, Sigal Heifetz, Howard Cuckle. (2003) Frequency of Down's syndrome and neural-tube defects in the same family. The Lancet 361:9366, 1331-1335
CrossRef273
BRIAN OLSHANSKY. (2003) Complementary and Alternative Medicine: The Need for Data. Cardiology in Review 11:2, 53-55
CrossRef274
Lynn L. Moore, M. Loring Bradlee, Martha R. Singer, Kenneth J. Rothman, Aubrey Milunsky. (2003) Folate Intake and the Risk of Neural Tube Defects: An Estimation of Dose-Response. Epidemiology 14:2, 200-205
CrossRef275
Harold Kalter. (2003) Teratology in the 20th century. Neurotoxicology and Teratology 25:2, 131-282
CrossRef276
Huiping Zhu, Robert Barber, Gary M. Shaw, Edward J. Lammer, Richard H. Finnell. (2003) Is Sonic hedgehog (SHH) a candidate gene for spina bifida? A pilot study. American Journal of Medical Genetics 117A:1, 87-88
CrossRef277
Zhu Li, Jacqueline Gindler, Hong Wang, RJ Berry, Song Li, Adolfo Correa, Jun-chi Zheng, J David Erickson, Yu Wang. (2003) Folic acid supplements during early pregnancy and likelihood of multiple births: a population-based cohort study. The Lancet 361:9355, 380-384
CrossRef278
M. A. G. Olde Scholtenhuis, T. E. Cohen-Overbeek, M. Offringa, P. G. Barth, Ph. Stoutenbeek, R. H. Gooskens, J. W. Wladimiroff, C. M. Bilardo. (2003) Audit of prenatal and postnatal diagnosis of isolated open spina bifida in three university hospitals in The Netherlands. Ultrasound in Obstetrics and Gynecology 21:1, 48-52
CrossRef279
Camilla Barrett, Alan Richens. (2003) Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop. Epilepsy Research 52:3, 147-187
CrossRef280
M.L. Watkins, S.L. Carmichael. 2003. PREGNANCY | Maternal Diet, Vitamins, and Neural Tube Defects. , 4737-4745.
CrossRef281
Joel G Ray, Chris Meier, Marian J Vermeulen, Sheila Boss, Philip R Wyatt, David EC Cole. (2002) Association of neural tube defects and folic acid food fortification in Canada. The Lancet 360:9350, 2047-2048
CrossRef282
Laura Mart
CrossRef283
T.W. Sadler, Alfred H. Merrill, Victoria L. Stevens, M. Cameron Sullards, Elaine Wang, Ping Wang. (2002) Prevention of fumonisin B1-induced neural tube defects by folic acid. Teratology 66:4, 169-176
CrossRef284
Lucia Lynn Kaiser, Lindsay Allen. (2002) Position of The American Dietetic Association. Journal of the American Dietetic Association 102:10, 1479-1490
CrossRef285
Richard S. Olney, Joseph Mulinare. (2002) Trends in neural tube defect prevalence, folic acid fortification, and vitamin supplement use. Seminars in Perinatology 26:4, 277-285
CrossRef286
Bengt A.J Källén, Petra Otterblad Olausson. (2002) Use of folic acid and delivery outcome: a prospective registry study. Reproductive Toxicology 16:4, 327-332
CrossRef287
Godfrey P. Oakley. (2002) Inertia on folic acid fortification: Public health malpractice. Teratology 66:1, 44-54
CrossRef288
Ignatia B. Van den Veyver. (2002) GENETIC EFFECTS OF METHYLATION DIETS. Annual Review of Nutrition 22:1, 255-282
CrossRef289
Don C Dyke, Phyllis J Stumbo, Mary J Berg Pharm, Jennifer R Niebyl. (2002) Folic acid and prevention of birth defects. Developmental Medicine & Child Neurology 44:6, 426-429
CrossRef290
Jennifer M. Burgoon, Jacob Selhub, Marie Nadeau, T.W. Sadler. (2002) Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model. Teratology 65:5, 219-227
CrossRef291
KEITH A. FREY. (2002) Preconception Care by the Nonobstetrical Provider. Mayo Clinic Proceedings 77:5, 469-473
CrossRef292
K. A. Frey. (2002) Preconception Care by the Nonobstetrical Provider. Mayo Clinic Proceedings 77:5, 469-473
CrossRef293
Raffaella de Franchis, Lorenzo D. Botto, Gianfranco Sebastio, Roberta Ricci, Achille Iolascon, Valeria Capra, Generoso Andria, Pierpaolo Mastroiacovo. (2002) Spina bifida and folate-related genes: A study of gene-gene interactions. Genetics in Medicine 4:3, 126-130
CrossRef294
PATRICIA A. JOHNSON, DIANE D. STADLER, MARCIA FELDKAMP, BEVERLY WEBBER. (2002) Impact of an Educational Seminar on High School Students’ Knowledge of Folic Acid Supplementation and its Role in the Prevention of Birth Defects. Journal of the American Dietetic Association 102:3, S78-S81
CrossRef295
Maureen Durkin. (2002) The epidemiology of developmental disabilities in low-income countries. Mental Retardation and Developmental Disabilities Research Reviews 8:3, 206-211
CrossRef296
Robert J. Berry, Zhu Li. (2002) Folic Acid Alone Prevents Neural Tube Defects: Evidence from the China Study. Epidemiology 13:1, 114-116
CrossRef297
Gideon Koren, Gil Klinger, Arne Ohlsson. (2002) Fetal Pharmacotherapy. Drugs 62:5, 757-773
CrossRef298
Marcia Feldkamp, Michael Friedrichs, John C. Carey. (2002) Decreasing prevalence of neural tube defects in Utah, 1985-2000. Teratology 66:S1, S23-S28
CrossRef299
Marcia Feldkamp, Michael Friedrichs, Kathryn Marti. (2002) Folic acid awareness, knowledge, and consumption among women of childbearing age in Utah, 1998-2000. American Journal of Medical Genetics 107:1, 67-69
CrossRef300
NJ Wald, MR Law, JK Morris, DS Wald. (2001) Quantifying the effect of folic acid. The Lancet 358:9298, 2069-2073
CrossRef301
Shiliang Liu, K. S. Joseph, Shi Wu Wen, Michael S. Kramer, Sylvie Marcoux, Arne Ohlsson, Reg Sauve, . (2001) Secular trends in congenital anomaly-related fetal and infant mortality in Canada, 1985-1996. American Journal of Medical Genetics 104:1, 7-13
CrossRef302
Andrew E. Czeizel, Magda Rockenbauer, Henrik T. Sørensen, Jørn Olsen. (2001) The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reproductive Toxicology 15:6, 637-646
CrossRef303
Britta M Ogle, Madelene Johansson, Ho Thi Tuyet, Lena Johannesson. (2001) Evaluation of the significance of dietary folate from wild vegetables in Vietnam. Asia Pacific Journal of Clinical Nutrition 10:3, 216-221
CrossRef304
Jacqueline Gindler, Zhu Li, RJ Berry, Jun-chi Zheng, Adolfo Correa, Xia-mei Sun, Lee-Yang Wong, Ling-chun Cheng, J David Erickson, Yu Wang, Qiao-ling Tong. (2001) Folic acid supplements during pregnancy and risk of miscarriage. The Lancet 358:9284, 796-800
CrossRef305
Judith Lumley, Lyndsey Watson, Max Watson, Carol Bower. (2001) Modelling the potential impact of population-wide periconceptional folate/multivitamin supplementation on multiple births. BJOG: An International Journal of Obstetrics and Gynaecology 108:9, 937-942
CrossRef306
Susan Moyers, Lynn B. Bailey. (2001) Fetal Malformations and Folate Metabolism: Review of Recent Evidence. Nutrition Reviews 59:7, 215-224
CrossRef307
Andrew E. Czeizel. (2001) Primary prevention of congenital abnormalities. Congenital Anomalies 41:2, 124-125
CrossRef308
Helga Refsum. (2001) Folate, vitamin B12 and homocysteine in relation to birth defects and pregnancy outcome. British Journal of Nutrition 85:S2, S109
CrossRef309
Karolin Stegmann, Julia Boecker, B
CrossRef310
Kamala Krishnaswamy, K. Madhavan Nair. (2001) Importance of folate in human nutrition. British Journal of Nutrition 85:S2, S115
CrossRef311
A Ericson, B Källén, A Åberg. (2001) Use of Multivitamins and Folic Acid in Early Pregnancy and Multiple Births in Sweden. Twin Research and Human Genetics 4:2, 63-66
CrossRef312
Linda A. Turner, Howard Morrison, Victor M. Prabhakaran. (2001) Do We Need Another Randomized Controlled Trial of Folic Acid Alone?. Epidemiology 12:2, 262-265
CrossRef313
Lynn L. Moore. (2001) Is the Jury Still Out on Folic Acid and Congenital Anomalies?. Epidemiology 12:2, 141-144
CrossRef314
Adrianne Bendich. (2001) Micronutrients in women’s health and immune function. Nutrition 17:10, 858
CrossRef315
Judith Lumley, Lyndsey Watson, Max Watson, Carol Bower, Judith Lumley. 2001. .
CrossRef316
T. J. Owen, J. L. Halliday, C. A. Stone. (2000) Neural tube defects in Victoria, Australia: potential contributing factors and public health implications. Australian and New Zealand Journal of Public Health 24:6, 584-589
CrossRef317
Sajjad A Ali, Demetrios L Economides. (2000) Folic acid supplementation. Current Opinion in Obstetrics and Gynecology 12:6, 507-512
CrossRef318
Hernández-Díaz, Sonia, Werler, Martha M., Walker, Alexander M., Mitchell, Allen A., . (2000) Folic Acid Antagonists during Pregnancy and the Risk of Birth Defects. New England Journal of Medicine 343:22, 1608-1614
Full Text319
Catherine Francis-Baldesari, Stanley H. Schuman. (2000) Epidemiology in Agromedicine. Journal of Agromedicine 6:4, 1-5
CrossRef320
Terence J O'Brien, Frank J Vajda. (2000) Contemporary management of epilepsy in pregnancy. The Australian and New Zealand Journal of Obstetrics and Gynaecology 40:4, 413-415
CrossRef321
Andrew E. Czeizel. (2000) Primary Prevention of Neural-Tube Defects and Some Other Major Congenital Abnormalities. Paediatric Drugs 2:6, 437-449
CrossRef322
Eugene P. Frenkel, Denise A. Yardley. (2000) CLINICAL AND LABORATORY FEATURES AND SEQUELAE OF DEFICIENCY OF FOLIC ACID (FOLATE) AND VITAMIN B12 (COBALAMIN) IN PREGNANCY AND GYNECOLOGY. Hematology/Oncology Clinics of North America 14:5, 1079-1100
CrossRef323
SeonAe Yeo, Michael Fetters, Yukio Maeda. (2000) Japanese Couples' Childbirth Experiences in Michigan: Implications for Care. Birth 27:3, 191-198
CrossRef324
Carl L. Keen, Sheri Zidenberg-Cherr. (2000) What are the best strategies for achieving optimal nutrition?. California Agriculture 54:5, 12-18
CrossRef325
John M. Quillin, Judy Silberg, Pamela Board, Lee Pratt, Joann Bodurtha. (2000) College womenʼs awareness and consumption of folic acid for the prevention of neural tube defects. Genetics in Medicine 2:4, 209-213
CrossRef326
Robert Barber, Stuart Shalat, Kate Hendricks, Brigitte Joggerst, Russell Larsen, Lucina Suarez, Richard Finnell. (2000) Investigation of Folate Pathway Gene Polymorphisms and the Incidence of Neural Tube Defects in a Texas Hispanic Population. Molecular Genetics and Metabolism 70:1, 45-52
CrossRef327
(2000) Neural-Tube Defects. New England Journal of Medicine 342:15, 1135-1137
Full Text328
(2000) Current Awareness. Prenatal Diagnosis 20:3, 267-273
CrossRef329
Botto, Lorenzo D., Moore, Cynthia A., Khoury, Muin J., Erickson, J. David, . (1999) Neural-Tube Defects. New England Journal of Medicine 341:20, 1509-1519
Full Text
- Letters
